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ABSTRACT
Xenopus earty response gene 1 is a matemally-cterived immediate-earfy gene
...mose expression is activated by FGF during mesoderm induction in Xenopus
embryos. The purpose of this project was to characterize the expression and
investigate the function of ER1 protein during earty development in Xenopus.
Analysis of the expression pattern of ER1 showed that the protein is present
in the earty embryo but retained in the cytoplasm until mid-blastula stages
after which it is translocated to the nucleus, first in the presumptive
mesoderm, then in the presumptive ectoderm, and finally in the endoderm.
Overexpression of the dominant negative FGF receptor XFD completely
blocks translocation of ER1 to the nucleus at mid-blastula suggesting that
nuclear translocation of ER1 is dependent on events triggered by FGF
signalling. Deletion analysis of stretches of acidic amino acid in the N-
terminal region of ER1 showed thai the protein has transactivation activity in
vitfO, suggesting that the protein may function as a transcription factor in vivo.
Overexpression of ER1 in embryos results in embryos with posterior
truncations, a phenotype similar to thai of embryos overexpressing XFD. RT-
peR analysis of molecular markers expressed during early development
showed that overexpression of ER1 downregulates the expression of Xbra,
BMP-4. and HoxB9. These results suggest that ER1 may function as an
endogenous, negative regulator of the FGF signalling pathway during
Xenopus embryogenesis.
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SECTION I
CHAPTER 1: GENERAL INTRODUCTION
1.1 FOREWORD
There has been considerable progress in recent years in identifying new
genes and in determining the function of their protein products, both in normal
biological systems, and in malfunctioning systems. Often, the identification of
genes and proteins only gives us a two-dimensional picture of their function in a
cellular system. tn order to gain a more complete understanding of how a
biological system functions, one needs to understand the dynamic interactions
that are ongoing at all times in cells, tissues and organisms. These interactions
involve a complex network of molecules that are turned on and off at specific
times through constant signalling and feedback loops. Model systems, both in
vivo and in vitro, have provided researchers with tools to test hypotheses on how
and why genes are expressed and how proteins interact with each other in
biological systems. Each model system presents strengths and weaknesses, but
together they have provided many insights into the functioning of organisms.
Model organisms, both vertebrate and invertebrate, are used for the study
of developmental processes. Reasoos for this include: ease of study, familiarity
with their development andJor genetics, and because of their biological interest
(Wolpert et a/., 2002). Some of these model systems such as the fruit fly
Drosophila melanogaster, the nematode Caenorhabditis elegans, sea urchins,
zebrafish, amphibians, chickens, rats and mice, have been studied widely.
The vertebrate group is comprised of a large number of different
organisms, all possessing the characteristic vertebral column. As adults, some
of these organisms are very different in their morphology. However, during the
early stages of their life cycle, atl vertebrate embryos undergo similar
developmental stages and pass through a phylotypic stage (where they resemble
each other) (reviewed in Galis & Metz, 2001). All vertebrate embryos start by
cleavage of the zygote after fertilization. Initially, the embryo repeatedly divides
into a number of smaller cells without a matching increase in mass. This process
is followed by gastrulation, a stage characterized by cell movements, which
results in the laying down of the germ layers determining the body plan. The
phylotypic stage occurs after gastrulation, and the vertebrate embryos more or
less resemble each other and have characteristic vertebrate features such as the
notochord, somites and neural tube. The notochord forms along the antero-
posterior axis and subsequently becomes incorporated into the vertebral column.
The brain and the spinal column are derived from the neural tube, which is
formed from ectodermal tissue lying directly above the notochord. The somites
develop into the vertebral column, muscles of the trunk, dermis and into limbs.
These structures are representative of all vertebrate classes (reViewed in Galis &
Metz, 2001).
The similarity in morphology during the early development of vertebrates
has loog been used to· justify the use of what may seem like a limited number of
developmental models to study development in general. The similarity in body
plan suggested that the processes that regulate development in different animals
might also be similar. In the last few years, molecular evidence has supported
the view that early development may be conserved at the gene level. With the
recent progress in the cloning of several genomes such as human, Drosophila
melanogaster, and Caenorhabditis e/egans, there is evidence that the genes
involved in the early development of organisms are conserved throughout
evolution not only between vertebrates but, as is the case tor certain ancestral
genes, even between vertebrates and invertebrates
Developmental models are often useful for studying cancer. It has been
shown that expression of these genes that are very tightly regulated during earty
development and is up- or down·regulated spatially and temporally in cells and
tissues with a high degree of precision may become misregulated in
developmental diseases and cancer. The various components of signal
transduction cascades, from the ligands and receptors initiating the cascades to
the transcription factors which effect a response at the DNA level, are potential
oncoproteins and tumor suppressor proteins. Loss of regulation at any step can
result in uncontrolled cell growth and in neoplastic growth (Powers at al., 2000).
The W()(k, in this thesis deals with the protein product of er1, a Xenopus
f8Svis gene, and attempts to provKIe further insight into its expression pattern
and its function during earty development.
1.2 Xenopus !aevls as a model organism for vertebrate development
Xenopus Isevis (Xenopus), the South-African clawed frog, has been useful
in elucidating some of the cellular, molecular and genetic mechanisms that
control cellular processes in vertebrates and has helped advance two important
areas in vertebrate biology: early embryonic development and cell biology. In the
past, the use of newts and salamanders was very common, and nowadays
Xenopus tropics/is is becoming more popular among developmental biologists
due to its potential for creating transgenics.
Xenopus {aevis has been critical in identifying basic embryonic processes
such as early fate decisions, patterning of the basic body plan, and
organogenesis. Xenopus has helped cell biologists and biochemists understand
chromosome replication, chromatin and nuclear assembly, cell cycle
components, cytoskeletal elements, and signalling pathways. Xenopus {aevis
presents many advantages for the study of development and cellular processes.
1. The frogs are relatively easy to raise and breed in laboratory conditions
and develop normally in tap water.
2. Eggs are easy to obtain in large quantities by stripping females
induced overnight with the human chorionic gonadotropin hormone
(HCG).
3. FertiliZation can be perfonnecl in vitro on a large number of eggs by
using sperm from testes removed from Xenopus males.
4. The embryos are hardy, highly resistant to infection and easy to
maintain in saline solutions.
5. The eggs are large -1 to 2 mm- in diameter and are very easy to
manipulate and dissect.
6. The life cyde of Xenopus is fully known.
1.3 Xenopus IBevis development
In this study, Xenopus embryos in the early stages of development (stage
1 to 45) were used. This section will highlight some of the major stages in the life
cycle of Xenopus (Figure 1.1) with emphasis on stages fertilization up to
gastrulation. Figure 1.1 shows stages 1, 6.5, 10 (gastrula), 13 (neurula), 22
(tailbud), 28 (late tailbud), 40 (tadpole) and adult frogs.
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Figure 1.1 The Ufe cycte of Xenopus laevls
The major devek>pmental stages and the approximate time
scale following fertilization at room temperature are shown
(reproduced from
http:Jcllrmed.ucalgary.ca/pv;whllTilbuttonsIXenCydeH.jpg).
1.3.1 Oogenesis
Xenopus females produce gametes or ova through the process of
oogenesis. Prior to oogenesis, primordial germ cells undergo mitotic cell
divisions and migrate to the genital ridge or future gonad (for review see Saffman
& Lasko, 1999). The primordial germ cells differentiate into eggs at the start of
meiosis. Adult females have eggs in different stages of development in their
ovaries; these stages are often classified according to their size, the smallest
being stage I and the largest stage VI. Growth from stage I to stage VI requires
about 8 months and during this time oocytes acquire the yolk, enzymes and
precursors of DNA, RNA and protein synthesis required by the embryo during
early development (Smith etal., 1991a).
It is during oogenesis that the animal-vegetal polarity is specified in the
egg. The animal hemisphere in the Xenopus egg is dar1<;ly pigmented, whereas
the vegetal hemisphere is unpigmented. During the earty stages of oogenesis,
the eggs are asymmetric with respect to their constituents, but as oogenesis
proceeds, pigment is localized to the animal hemisphere and largest yolk
granules to the vegetal. Yolk synthesis and deposition in the eggs occurs by a
process known as 'Vitellogenesis' and is triggered by environmental cues. These
signals stimulate the release of gonadotropin-releasing hormone from the
hypothalamus, which itself stimulates the release of gonadotropins by the
pituitary. These gooadotropins signal the follicle cells of the ovary to release
oestrogens, which circulate to the liver where vitellogenin is made. The
vitellogenin is carried to the eggs for uptake. Yolk is a highly important
constituent of the egg because it is the only food source available to the embryo
during ear1y development. other matemal constituents such as glycogen
granules, ribosomes, lipochondria, endoplasmic reticulum and the germinal
vesicle (nucleus) translocate towards the animal hemisphere and matamal RNA
localizes to different regions of the egg (Danilchik and Gerhart, 1987). The
matemal RNA transcribed during oogenesis suffices to meet all the reqUirements
of the embryo until it initiates transcription of its own RNA at the mid-blastula
transition (MBT), which occurs after the 121h cleavage cycle (Newport & Kirshner,
1984).
The oocytes arrest in the first meiotic cycle at the G2IM transition at stage
VI unless stimulated (Smith at al., 1991). Eggs can remain in this state for
several months until environmental cues prompt the follicle cells surrounding the
oocytes to produce the hormone progesterone, which causes the resumption of
meiosis and ovulation. Unstimulated eggs will usually undergo atresia (Hunt,
1989; for reviews see Sagata, 1988, Ferel!, 1989). In the laboratory, females are
stimulated to complete ovulation by an injection of HCG, which causes the stage
VI oocyI.es to mature to the second meiotic metaphase followed by ovulation
(reviewed in Wolpert at 81., 2002). Females can be manually harvested of the
mature eggs about 14-18 hours after stimulation with HCG and fertilized in vitro
with spann obtained from adult males
1.3.2 Fertilization
Fertilization is triggered by the sperm entering the egg (Fig. 1.2A). Fusion
of the sperm and egg plasma membrane causes a rapid release of free calcium
ions from the egg's endoplasmic reticulum into the egg's cytoplasm. As a result
of the high levels of intracellular calcium, the egg membrane becomes
depolarised and cortical granules are released into the space between the egg
and the vitelline membrane (an acellullar membrane surrounding the plasma
membrane). The vitelline membrane prevents polyspermy. Calcium release also
causes the activation of the enzyme, calmodulin-dependent protein kinase II.
This enzyme causes the degradation of the eyelin component of maturation
promoting factor (MP'F) causing the egg to re--enter and complete meiosis
(Nuccitelli, 1991; Wanatabe at a/., 1991; Runft et al., 1999).
The sperm and egg pronuclei fuse to form the zygote nucleus. The
vitelline membrane lifts off the surface of the egg and the egg rotates under the
influence of gravity so that the heavier, yolky, vegetal region is facing downward.
(reviewed in Wolpert et a/., 2002)
1.3.3 Cortical rotation and establishment of the future dorsal side
Before fertilization, the Xenopus egg has a radial symmetry along the
animal-vegetal axis, which is broken by sperm entry. The dorsal side forms
opposite the sperm entry point (reviewed in Harland & Gerhart, 1997). The
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series of events triggered when the sperm enters the egg result in the definition
of the dorsa-ventral axis of the embryo. Within 90 minutes of fertilization, the
plasma membrane and the cortex opposite the spenn entry point perform a 30°
rotatiOl1 in the direction of the sperm entry point relative to the rest of the
cytoplasm, a process known as cortical rotation (Fig. 1.28) (reviewed in Harland
& Gerhart, 1997).
Cortical rotation results in the formation of a signalling center in the
vegetal region opposite the site of sperm entry. This signalling center has been
named the Nieuwkoop center, after the embryologist Peter Nieuwkoop. The
Nieuwkoop center is a vegetal dorsalizing center, which signals to the
surrounding tissues and determines dorso--ventral polarity in the embryo (Fig. 1.2
C) (reviewed in Harland & Gerhart, 1997)
II
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\, __/ •• 0
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Figure 1.2: Fertilization, cortical rotation and establishment of future
dorsal side
After fertilization (A), the cortical layer rotates 30 degrees
towards the site of sperm entry (8), and results in the formation
of the Nieuwkoop centre opposite the site of sperm entry. Later,
the Spemann organizer and the blastopore form in a region just
above the Nieuwkoop centre (C). V=ventral; D=dorsal (adapted
from Wolpert at a/.• 1998).
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1.3.4 Cleavage events, blastula stages and patterning events
The first cleavage occurs about 90 minutes after fertilization and passes
through the point of sperm entry and through the Nieuwkoop center. The embryo
divides into two equal halves. SUbsequent cleavages occur at intervals of about
20-30 minutes. The second cleavage is also along the animal-vegetal axis but at
right angles to the first. The third cleavage is equatorial and at right angles to the
first two and results into four smaller animal cells and four bigger vegetal cells
known as blastomeres. The difference in size of animal and vegetal cells is a
direct result of the unequal distribution of yolk in the embryo. The blastomeres
keep dividing at regular intervals without any increase in cell mass. These
continued synchronous divisions result in a spherical mass of cells inside which a
fluid-filled cavity, the blastocoel, develops. The embryo is now known as a
blastula (reviewed in Jones & Smith, 1999).
After about 12 cycles of cell divisions, the embryo reaches a stage known
as mid-blastula transition (MBT). This stage is characterized by a slO'Ning of the
mitotic rate, the beginning of asynchronous cell divisions, the onset of zygotic
transcription and cell motility (Newport and Kirshner, 1984; Masui and Wang,
1998).
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1.3....1 Patterning of the Xenopus blastula
The different regions in the embryo, the animal region, the marginal region
(a belt~like region dividing the animal and vegetal regions), and the vegetal
region, give rise to the three germ layers: the ectoderm, mesoderm, and
endoderm, respectively (Fig. 1.3A). The ectoderm later covers the entire surface
of the embryo and farms the epidermis; ectodermal derivatives also give rise to
nervous tissue. The mesoderm differentiates into the notochord, lateral plate
(which farms heart, kidney and blood islands), and somites (Boterenhood &
Nieuwkaop, 1973). The lining of the gut and gut-associated organs such as the
liver and pancreas are derived from the endoderm (Fig. 1.3B). The late blastula
stage embryo is a sphere of cells consisting of the Mure ectoderm, mesoderm
and endoderm (Fig. 1.3) (Dale & Slack, 1987; reviewed in Harland & Gerhart,
1997).
By the time the Xenopus egg is laid. there are already differences along
the animal-vegetal axis. Maternal factors are thought to determine the fates of
the ectodermal and endodermal regions. For example, if explants from the
different regions of the early blastula are cultured in simple salt medium, explants
from the animal region will farm an epidermal ball of cells whereas explants from
the vegetal region will be endodermal in nature (Nieuwkoop, 1969; Boterenhaod
& Nieuwkoop, 1973). These results match the expected fates of these regions
and there is no evidence that signals from other regions are required. However,
14
if an explant from the animal region is cultured in combination with an explant
from the vegetal hemisphere, it is induced to form mesodermal deriVatives. whid'l
normally result from explants from the marginal zone only (Boterenhood &
Nieuwkoop, 1973; reviewed in Isaacs, 1997).
IS
AnImal
A.
Marginal
1Iege""
Animal
B. Ventral
Vegetal
Agure 1.3 Fate map of the Xenopus embryo
A. The Xenopus embryo showing the animal, marginal and
vegetal regions which will develop into ectoderm. mesoderm
and endoderm respectively. B. A fate map of the Xenopus
blastula (lateral view) illustrating the normal fates of the different
blastula regions (adapted from Keller, 1975; Keller 1976; Dale
and Slack 1987; reproduced from Wolpert at al., 199B).
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It is now widely accepted that inductive cell interactions between the
animal and vegetal hemispheres control the differentiation of the mesodermal
embryonic germ layer. landmark experiments by Nieuwk.oop (1969)
demonstrated that vegetal cells induced animal cells to form mesoderm. One of
the most important and famous experiments demonstrating the presence of
inducers during mesoderm induction and embryonic axis formation was
performed by Spemsnn and Mangold in 1924. They transplanted a section of the
dorsal marginal zone from one embryo into the ventral side of a second embryo
and obtained an embryo with two body axes. These results demonstrated that
cells of the dorsal marginal zone were responsible for the formation of dorsal
mesodermal structures such as the notochord, in addition to specifying or
organizing the antero--posterior body axis. In these experiments, it was
effectively shown that cells of one type, dorsal mesoderm, had the ability to
induce the formation of mesodermal derivatives in other cells. This region of the
dorsal marginal zone subsequently became known as the 'Spemann organizer'
(Figure 1.2) (reviewed in Harland & Gerhart, 1997).
It has been proposed that signals are established by general mesoderm
inducers shortly after cortical rotation, which is triggered by sperm entry in the
egg and causes the division of the vegetal cytoplasm into ventrovegetal and
dorsovegetal regions. Cortical rotation involves the establishment of a parallel
array of micrctubules in the vegetal hemisphere along which the cortex is thought
to move (Elinson & Rowning, 1988). Disruption of the microtubule array by
J7
ultraviolet radiation prevents cortical rotation, and results in embryos lacking an
embryonic axis (Gertlart et 81., 1969). Conversely, manual tipping or
centrifugation of egg during the first cycle causes a duplication of the axis
(Gertlart et 81., 1969). Cortical rotation establishes a dorsal determining activity
region opposite the point of sperm entry, the Nieuwkoop centre, which induces
the Spemann's Organizer. In tum, the organizer establishes dorso-ventral
polarity in the embryo (reviewed in Moon & Kimelman, 1998).
In recent years, a widely accepted model for mesoderm patterning, the
Three Signal Model (Smith & Slack, 1963) has been proposed (depicted in
Figure 1.4). The Three Signal Model proposes that mesoderm patterning is
initiated by early signalling, from general mesoderm inducers released by the
vegetal region to the animal region. The first set of signals originates in the
dorsovegetal (DV) region (Nieuwkoop centre) and induces the formation of dorsal
mesoderm, including the Spemann's organizer. The inducing factors from the
ventrovegetal 0fV) region induce the marginal zone cells directly overlying them
to broadly specify ventral-type mesoderm such as mesenchyme, mesothelium
and blood. Subsequently, the third signal, a dorsalizjng inductive signal,
emanates from the organizer and imposes more dorsal or paraxial (resulting in
the formation of notochord) and intermediate fates (such as muscle) on
neighbouring ventral mesoderm at gastrula stages (Smith & Slack, 1983; Dale at
sl., 1985; reviewed in Harland & Gertlart, 1997).
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The model described above does not necessarily imply only three distinct
signalling molecules. It is possible that each signal represents more than one
molecule or one molecule acting at several different concentration gradients.
Some of the inducing and competency factors involved in mesoderm induction
have been identified and will be discussed further in the next section.
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Figure 1.4 The three-signal model of mesodenn Induction
Shown are the origins and actions of the three signal types involved in mesoderm
induction. During mesoderm induction, the dorsovegetal (DV) region induces the
organizer (0) and the ventrovegetal (W) region induces ventrally specified
mesoderm (M3) in the marginal zone. Signals from the organizer region
·dorsaHze~ the ventral mesoderm to give regions of lateral mesoderm (M1 and
M2). A = animal hemisphere. (adapted from Smith & Slack, 1983).
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1.3.4.2 -Molecules that pattem the mesoderm
Several molecules have been shown to induce mesoderm in animal cap
explants in culture. However, to be qualified as a natural inducer in the embryo,
several criteria need to be met by potential mesoderm-inducing proteins. These
criteria include the presence of the inducing protein in the right concentration and
at the right time in the vegetal region of the embryo; showing that the appropriate
cells can respond to the factor; and that blocking the response prevents induction
(reviewed in Harland & Gerhart, 1997). Furthermore, it is thought that the
mesoderm-inducing molecules are most likely to be secreted. It has been shown
that when isolated animal and vegetal cell fragments are cultured together but
separated by a filter with pores too small to allow cell contacts to develop, the
animal cells still differentiate into mesoderm (Slack, 1991). This demonstrates
that mesoderm induction is due to small, secreted diffusible molecules prodUced
by the vegetal region (Slack, 1991). It has also been shown that mesoderm
induction starts at around the 32-cell stage and is almost complete by the time
gastrulation starts (Dale & Slack, 1987). Nakamura and Takasaki (1970) showed
that the equatorial region of the embryo formed mesoderm in culture only after
the 64-ce1l stage; before this they would differentiate into epidermis. Therefore,
natural mesoderm inducers are most likely maternally-derived factors that are
present in the vegetal hemisphere and induce overlying animal cells to form
mesoderm.
2\
Although there is still a debate as to which moleculeJs actls as the general
mesoderm inducer released by the W region, several candidates have been
proposed. It is generally agreed that TGF-p proteins play a key role in
mesoderm induction (reviewed in Kessler & Melton, 1994; Jones 8t af., 1995;
Smith st a/., 1995). The various members of the TGF-p family implicated in
mesoderm induction are activin (Asashima 8t at, 1990, Smith at aI., 1990;
Thomsen at aI., 1990); Vg1 (Thomsen & Melton, 1993); TGF-p2 (Rosa at aI.,
1988) and Xenopus nodal-related 1 and 2 (Xnr1, Xnr2) (Jones at al., 1995).
Bone morphogenetic proteins (BMPs) have also been shown to have ventral-
mesoderm inducing activity at high doses (Wilson & Hemmati-Brinvanlou, 1995).
Signalling by p-catenin (Heasman et 81., 1994) is also important during
mesoderm induction (discussed later) and FGF signats have been shown to be
necessary for the maintenance of induced mesoderm (Amaya st aI., 1993;lsaacs
at 91.,1994).
Although the mature, active protein products of the various molecules
listed above can induce mesoderm in animal cap explants in vitro, it has been
difficult to block the actiVity of specific proteins in order to show their importance
(reViewed in Harland & Gerhart, 1997). All of these molecules are present in the
form of mRNA and/or protein in the embryo or are transcribed in the lale blastula.
When a dominant negative TGF·~ family receptor, activin type liB receptor
(XAR1; lacking most of the cytoplasmic portion of the receptor), is injected in the
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embryo at an early stage, mesoderm formation is prevented (Hemmati-Brinvalou
& Melton, 1992), and signalling by aetivin (Hemmati-Brinvanlou & Melton, 1992),
Vg1 (Shulte-Merker at al., 1994), and BMPs (Hemmati-Brinvanlou & Thomsen,
1995) is blocked. These experiments implicate a TGF-p in the induction of the
mesoderm but do not identify a specific family member.
Activin is a potent mesoderm inducer of animal cap explants in culture but
is thought to be an unlikely inducer in the embryo since follistatin, an inhibitor of
activin, has been shown to blocl<. the activity of activin added to animal caps but
not to prevent mesoderm induction (Shulte-Merker et al., 1994, Kessler & Melton,
1995). Another attractive candidate for general mesoderm induction is Vg-1,
which is expressed from matemal RNA localized to the ventral region of the
embryo. Like other members of the TGF-13 family, Vg-1 has to be proteolytically
cleaved in order to be active. Researchers have shown that mature, processed
Vg-1 induces mesoderm when injected into animal cap explants (Thomsen &
Melton, 1993; Kessler & Melton, 1994; Forristall at al., 1995). Although
processed/active forms of Vg-1 have not yet been detected in the embryo,
inhibition of Vg-1 with a dominant-negative mutant leads to defects in dorsal
mesoderm formation (Joseph & Melton, 1998).
Using antisense oligodeoxynucleotides to deplete maternal mRNA, it has
been also been shown that VegT, which encodes a transcription factor containing
aT-box, is a matemal determinant required for early embryonic events (Zhang at
al., 1998).
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Zygotic signals such as Derriere and the NodaJ..related genes Xnrf, Xnr2
and Xnr4 are also involved in mesoderm induction (Zhang at al., 1998; Kimelman
& Griffin, 1998; reviewed in Kimelman & Griffin, 2000). The expression of Xnrf,
Xnr2, and Xnr4 starts at midblastula can be activated synergistically by VegT and
Vg-1 (Zhang at al.• 1998, Joseph & Melton, 1998; Agius at af" 2000) acting
together wnh the dorsal determinant f}-catenin (Heasman at 81., 1994;
Scheneider at al., 1996). Endogenous Xnrf. Xnr2, and Xnr4 are expressed
zygotically in the blastula endoderm in a graded fashion with a maximum in the
dorsal endoderm (Agius at aI., 2000). These zygotic factors can induce both
ventral and dorsal mesoderm. It has been proposed that a gradient of Nodal-
related signals, released by the endoderm during mesoderm induction, may be
acting as the first two signals in the three-signal model (Agius at af., 2000). VegT
can also activate Derriere. Derriere is functionally different from the Xnrs as it
seems to be required only in trunk and tail development, in contrast to Xnrs,
which are required throughout the body (Kofron at al., 1999; Piccolo at al., 1999;
Sun et al., 1999).
Members of the FGF family have also long been considered prime
candidates as mesoderm inducing factors (Slack, 1994). FGF-2 (bFGF) and
eFGF (Isaacs at al., 1992; Tanahill at af., 1992; Song & Slack, 1994; Song &
Slack, 1996) have been proposed as mesoderm inducers. However, recent work
has shown that during blastula stages the FGFs do not act as vegetally localized
inducing signals. Instead, they are required in the animal hemisphere as
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competence factors that are required in the animal hemisphere for the full range
of responses to the vegetally localized molecules (reviewed in Isaacs, 1997). In
contrast to the data obtained using the dominant negative activin receptor, which
suggest that the TGFp signalling pathway is required for the expression of all
mesodermal genes (Comell at at, 1995), FGF function is required for the correct
regulation of only a subset of the genes that are expressed throughout tha newly
formed mesoderm (reviewed in Harland & Gerhart, 1998).
Several molecules have been identified as the potential dorsal and ventral
signals (Figure 1.5). An essential component of the Wnt signalling pathway, the
protein kinase, Glycogen synthase Kinase-3 (GSK-3) has been implicated in the
normal suppression of dorsal fates. When GSK-3 activity is blocked by injecting
dominant-negative GSK·3 mutants in the embryo on the ventral side of the
embryo, a secondary axis is i~duced on the ventral side of the embryo indicating
that GSK-3 normally functions to suppress dorsal axis formation (Dominguez et
81., 1995; He et 81., 1995; Pierce & Kimelman, 1995). GSK·3 regUlates the level
of the dorsal determinant, ~-catenin, in the embryo by phosphorylation, which
tags ~catenin for proteolysis. (3-catenin is a transcription factor which is a
member of the Wnt ~ignalling pathway and has been identified as a potential
early dorsal determinant involved in inducing actiVity (reViewed in Moon &
Kimelman, 1998). Activation of Wnt signalling or overexpression of the
dominant-negative kinase, prevents phosphorylation and stabiliZes ~-catenin.
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Lithium had been shown to dorsalize Xenopus embryos when added or injected
at early cleavage stages much before the identification of any of the signalling
molecules in axis specification (Kao at al., 1989). It has now been shown that
lithium acts as a non-eompetitive inhibitor of GSK-3 in vitro (Klein & Melton,
1996; Stambolic et al., 1996) and stablilizes p-eatenin in cultured cells and
Xenopus embryos (Stambotic at al., 1996; Larabell at al., 1997). These results
suggest that lithium dorsalizes Xenopus embryos by increasing the levels of (}-
catenin in the embryo (Moon & Kimelman, 1998).
During early cleavage stages, p-eatenin becomes enriched in the
cytoplasm in the dorsal side of the embryo and by 16- to 32-ce1l stages is found
in the nuclei of the dorsal side (Heasman, 1997; Moon & Kimelman, 1998),
where it binds the HMG Box factor, XTd-3. Expression of a XTd-3 mutant
lacking the f}-catenin binding domain blocks the formation of the dorsal axis in
Xenopus (Molenaar et af., 1996). The association of f}-catenin with XTd-3 in the
nuclei is believed to be required for the specific expression of dorsal genes
during late blastula stages (reviewed in Moon & Kimelman, 1996). XTcf-3
directly binds the siamois promoter and activates the gene. Siamois is a
homeobox gene encoding a transcription factor (Lemaire et al., 1995). It is
thought to play a major role in the specification of Spemann's organizer
(Heasman, 1997; Moon & Kimelman, 1998). A dominant- inhibitory mutant of
siamois created by fusing the repressor domain of the Drosophila engraifed gene
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to the homeodomain of siamois blocks axis development and the expression of
organizer-specific genes such as goosecoid (reviewed in Moon & Kimelman,
1998). Goosecoid in tum activates other organizer genes such as chordin (Sasai
at aI., 1994).
After the induction of the organizer, further patteming subdivides the
mesoderm into mesodermal subdomains along the dorso-ventral axis. Molecules
such as BMP-4, Xwnt-8, Derriere and FGFs have been to be proposed
molecules, present throughout the marginal zone, which act as ventralizing
factors in the mesoderm (Figure 1.5) (revieWed in Moon & Kimelman, 1998). The
activity of these ventralizing factors is controlled by dorsalizing signals,
emanating from the Spemann's organizer (Figure 1.5) The dorsalizing
molecules include noggin, chordin and frizbee, which act as anti-ligands by
binding to the ventralizing factors and hence preventing the latter from binding to
their receptors. Noggin and Chordin bind with BMP-4 and prevent it from binding
to its receptor (Kessler & Melton, 1994; Zimmerman et af., 1996; Piccolo at a/.,
1996; reviewed in Moon & Kimelman, 1998). Frlzbee acts by interacting with
Wnt proteins (Leyns et a/., 1997; Sokol. 1999). Therefore, the mesoderm is
probably patterned in a dose-dependent manner according to the distribution of
the ventralizing factors and the localization of their inhibitors. The Spemann's
organizer has been proposed to act as an anti-ventralizing zone, releasing
dorsalizing factors, which inhibit the ventralizing factors. The cells near the
organizer are therefore able to give rise to more dorsal-type mesoderm whereas
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the tissues furthest from the organizer, which do not 'see" dorsalizing signals,
give rise to more ventral-type mesoderm.
For mesoderm induction to occur, the signalling molecules described
above must bind specific cell surface receptors and activate signal transduction
pathways which mobilize transcription activators and result in transcription of
specific genes which specify and pattern mesoderm. Examples of early
response zygotic activated genes that encode transcription factors are Xbra,
goosecoid, chordin, pintavallis, HNF-3p, Xnot, and Xlim-1 (Smith et a/., 1991;
Taira at a/., 1992; von Dassow at a/., 1994; Ang & Rossant, 1994; O'Reilly et af.,
1995). The genes activated by these transcription factors remain largely
unknown but they are likely to encode secreted proteins such as noggin and
frizbee. Goosecoid, for example, has been shown to activate the dorsal
signalling gene chordin, (Heasman, 1997; Moon & Kimelman, 1998).
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Figure 1.5 A mesoderm induction and patterning schematic showing a revised version
of the Three-Signal Model with some of the molecules implicated. Vg-1
may act as the first signal or general mesoderm inducers. p-catenin binds
to XTcf-3 and induces the expression of Siamois in the Nieuwkoop Centre
on the dorsal side of the embryo. These molecules act as the second
signal and induce the formation of the organizer. The Nodal-related Xnrs,
which are activated by VegT may also be acting as both s19nal1 and 2 in a
dose dependent manner. Noggin, Chordin and Frizbee, which are
released by the Organizer, act as Signal 3 by inhibiting molecules such as
BMP-4, Xwnt-8, Derriere and FGFs which expressed throughout the
marginal zone and give rise to ventral type mesoderm. Signal 3 results in
more dorsal mesodermal type tissues in the organizer region
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1.4 FGFs in mesoderm formation
FGFs are thought to playa two-part role during mesoderm induction. It has
been suggested that maternal FGFs act to provide sub-threshold stimulation of
the tyrosine kinase pathway in the animal hemisphere. The second function of
FGF during mesoderm induction is the maintenance of mesodermal genes.
FGFs act as competence factors which are required for the full range of
response to vegetally localized mesoderm inducers (reviewed in Isaacs, 1997).
It has been shown that FGFs can induce mesoderm in animal cap explants in
culture and that the type of mesoderm induced by FGF is concentration-
dependent: at low doses of FGF, there is ventral mesoderm formation (such as
mesothelium) while higher doses induce more lateral type mesoderm such as
muscle (Slack et a/., 1987; Slack et af., 1988). Furthermore, expression of a
dominant-negative FGF receptor (XFD) inhibits mesoderm formation in animal
caps and causes defects in trunk and posterior development in embryos (Amaya
at 8/.. 1991; Kessler & Melton. 1994). It has been proposed that FGFs may
potentiate the response of animal cap celis to TGF-13-like molecules and that they
are involved in the control of cell movements and gene expression in the early
mesoderm (Isaacs etal., 1994).
Therefore, rather than being primary inducing factors, FGFs are
competence factors that are required for mesoderm induction by general
mesoderm inducers. They are also required for the continued expression of a
number of mesodermal genes (Dyson & Gurdon, 1997; reviewed in Isaacs,
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1997). In support, ablation of FGF signalling affects primarily induction of ventral
type mesoderm (Amaya et a/., 1991; Kessler & Melton, 1994). The low level of
activity of matemal FGFs is necessary for the transcription of the mesodermal
gene, Xbra (Isaacs et al., 1994; Schulte-Merker & Smith, 1995), the Xenopus
homologue of the Brachyury gene, an early response gene expressed throughout
the mesoderm and encoding a transcription factor (Smith et al., 1991b). Xbra
aets in an autocatalytic loop to induce eFGF, which may function as a mesoderm
secondary inducing factor (reviewed in Isaacs, 1997).
eFGF is necessary for the maintenance of Xbra. Injection of Xbra mRNA in
the presumptive ectoderm causes formation of ventral mesoderm and further
supports a role for Xbra and FGF in mesoderm patterning (Cunliffe & Smith,
1992; Cunliffe & Smith. 1994).
FGFs are among the major regulators of patterning of the developing
embryo. The activities of FGFs dUling embryonic development appear to depend
on FGF regulation of several fundamental life functions: the abilities to survive,
replicate, make attachments, move, and attain a characteristic form (reviewed in
Szebenyi & Fallon, 1999).
The next three sections will provide a brief overview of the structure and
function of FGFs, FGF receptors and FGF signal transduction pathways.
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1.4 FGFs - Structure and Function
FGF was first purified from bovine pituitary gland as a mitogen that could
stimulate the grc>'Nth of NIH3T3 cells (reviewed in: Burgess and Maciag, 1989;
Mason, 1994; Galzia et a/., 1997; McKeehan st 8/., 1998; Kato and Sekins, 1999;
Szebenyi and Fallon, 1999; Ornitz 2000; Powers at 8/., 2000). Since the initial
discovery of FGF, approximately 25 years ago, 20 FGFs (Table 1.1), among
which are some FGF homologous factors (FHFs 1--4; also referred to as FGFs
11-14, which comprise a separate branch of the FGF family and have been
implicated in the development of the nervous system and limbs), have been
identified in vertebrate species. Four FGF receptors (FGFRs) have been
identified in vertebrates, t'NO FGFRs and one FGF have been identified in
Drosophila and one FGF/FGFR has been identified in C. elagans (Szebenyi &
Fallon, 1999).
Historically, the first FGFs cloned (FGF-1 and 2) were shown to have
mitogenic activity in fibroblasts, hence the name fibroblast growth factor.
However, structure and heparin-binding ability, not specifically growth promoting
activity, is the defining feature of the FGF family (Powers at al,. 2000). Although
by no means exhaustive, Table 1.1 shows a sample of the functions of FGF
family members. Therefore, although the members of the FGF family are
collectively referred to as "FGF" followed by a numerical designation (Table 1.1),
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each exerts different biological actions through specific high-affinity receptors
(FGFRs) (Powers et 81" 2000).
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Tabla 1.1 Characteristics of the members of the FGF family (adapted from Powers et al., 2000
and Szebenyi & Fallon, 1999)
N.m~ Synonym Species Sipal Comments
sequena
FGF- Acidic
, FGF,
aFGF
FGF- Basic
2 FGF,
bFGF
FGF- Kaposi
4 FGF,
KFGF,
hst-'
FGF-
5
FGF- Hst·2
6
FGF- KFGF
7
FGF- A1FGF
8
FGF- GAF
9
Human,
hamster,
bovina, Absarrt
rat, pig,
chicl<.,
moo..
Human,
opossum,
bovine,
rat, chicl<., Absent
moo",
sheep,
Xenopus,
-Human,
chick,
'''',mouse, Present
Xenopus
Human,
chicl<.,
mouse, Present
bovine,
Xeno s
Human,
mouse, Present
cat
Human,
mouse Present
Human,
mouse, Present
rat,
sheep,
doo
Human,
'mouse,
chicken, Present
XenoDUS
Human,
rat, Absent
=~s
1 mRNA form, nuclear localization motif, mitogenic,
angiogenic, induoes limb bud formation
4 protein isoforms through the use of alternate start
codons, some isoforms have nuclear localization
motifs, mitogenic, mesoderm inducing factor in
Xenopus, angiogenic, induces limb bud formation,
may be involved in apoptosis, highly expressed in
human gliomas
Site of MMlV integration in mouse genome, nuclear
localization motif, exprassed primarily during
development, mesoderm inducing factor in Xenopus,
involved in induction of inner ear, activated in mouse
mammary carcinogenesis and tumorigenic clones of
human colon cancer cell lines
Identified by screening stomach tumours and Kaposi's
sarcoma, induces limb bud formation
Regulatory factor in gastrulation, expressed in
pancreatic cancer-associated macrophages and
fibtoblasts
Specific for epithelial cells, mitogenic, angiogenic
7 isoforms, involved in migration of mesenchymal cells
2NiaY from the primitive streak in mouse emblyos,
~~~I~~~:a~~::~~i:e~~::~i:emjng
Not angiogenic
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FGF· KGF-2 Human, Similar in structure and function to FGF-7, involved in
'0 rat, chick, Present lung development
mouse
FGFs FHFs Human, All contain nuclear localization motifs
,,- ~'"
"
(FGF-
11), Absent
Human,
mouse,
chicken
(FGFs
12-13).
mouse
FGF 14
FGF· Moo," Activated by E2A-Pbxl
15
FGFs Rot
,6- Present
"FGF- XFGF- Xenopus SeQuence homology to FGF-9
20
20
35
FGFs have been implicated in numerous cellular processes such as
regulation of cell growth, survival, differentiation, migration, angiogenesis,
chondrogenesis, morphogenesis, wound healing. skeletal formation,
tumorigenesis, and metastasis (Kato and Sekine, 1999; Omitz, 2000) and are
produced at some point during the development of each of the four histological
tissue types (epithelial, muscle, connective, and nervous tissue) (Szebenyi and
Fallon, 1999).
FGFs form a family of structurally related polypeptide growth factors
(Figure 1.6 shows a generic FGF protein). which range in molecular weight from
17 to 34 kDa in vertebrates, and up to 84 kDa in Drosophila (Omitz, 2000).
Members of the FGF family share a strong affinity for heparin and heparan-like
glycosaminoglycans (HLGAGs) (Burgess & Maciag, 1989).
The most conserved sequence within the FGFs is a core of 120 amino
acids. where FGF orthologs (divergence resulting from speciation) are 71-100%
and FGF paralogs (divergence due to gene duplication resulting in several
isotypes within a single species) are 22-66% identical (Szebenyi & Fallon, 1999).
This core region does not contain a secretory signal. The mechanisms whereby
some members of the FGF family such as FGF-1, ·2, -9, ·11, -12, -13, -14 are
secreted by cells is still unknown but may be dependent on novel
uncharacterized secretory pathways (Femig & Galllagher, 1994; Szebenyi &
Fallon, 1999; Powers et 81., 2000). Other family members such as FGF·3 to-8
and FGF-10 have a consensus signal sequence found near the AUG translation
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initiation site (Figure 1.6) and are targeted for secretion through the endoplasmic
reticulum.
Some FGF family members. such as fgf~2 and fgf~3 make use of
altemative 5' CUG translation initiation sites as well as the canonical AUG codon
(Figure 1.6) and yield high and low molecular weight proteins. The protein
isoforms have different subcellular localization; the high molecular weight forms
of FGF-2 contain nuclear localization sequences and localize to the nucleus
whereas the low molecular weight form is cytoplasmic. The high and low
molecular weight forms associate with distinct sets of proteins and have a
different range of biological activities (Bivfalvi at al., 1995; Patry et aI., 1997)
Post-translational modifications of FGFs include gtycosylation,
phosphorylation and ADP-ribosylation (Figure 1.6) (Szebenyi & Fallon, 1999).
Glycosylation may have a role in modulating interactions between FGFs and
proteases. Mutating the glycosylation site in FGF-4 results in cleavage of FGF-4
prior to secretion resulting in peptides that are biologically more active than the
full-length protein (Bellosta et al., 1993). The phosphorylation state of some
FGFs such as FGF-2, which is phosphOf)'lated on threonine 121, regulates their
binding affinity for their receptors (Baird, 1994).
A number of different FGFs have been identified during the early stages of
embryonic development in Xenopus. To date, four members of the FGF family
have been identified in Xenopus (reviewed in Isaacs, 1997). These are FGF~2,
FGF~3, eFGF and FGF-9. FGF-2, eFGF and FGF-S all show matemal and
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zygotic expression in Xenopus. FGF-3 becomes expressed in the embryo after
the onset of zygotic transcription (reviewed in Isaacs, 1997). Both FGF·2 mRNA
and protein are present in the early embryo. At blastula stages, FGF-2 is present
predominantly in ~he animal hemisphere (Song and Slack, 1994). At later stages
(neurula and tailbud), FGF-2 has widespread expression in the central nervous
system and somatic tissue (Song and Slack, 1994). FGF·3 has a posterior
domain of expression in the mesoderm of the blastopore region of the Xenopus
gastrula and in the anterior domain of the ectoderm; at later stages, the posterior
domain becomes localized to the tailbud and the anterior domain breaks up into
a complex pattern of expression in the head (reviewed in Isaacs, 1997). FGF·9
is present throughout early development with materna! expression being primarily
in the animal hemisphere and later zygotic expression throughout the whole of
the developing axis (reviewed in Isaacs, 1997) The maternal expression of
eFGF is primarily in the animal hemisphere. At gastrula stages eFGF is
expressed zygotically in a ring around the blastopore region with a higher
expression level on the dorsal side of the embryo (Isaacs et aI., 1996). In late
gastrula and early neurula stages eFGF expression ;s seen in the blastopore
region and in the notochord. SUbsequently, eFGF becomes localized to the
extreme posterior of the embryo in the chordoneural hinge and posterior wall of
the neuroenteric canal at late neurula and tailbud stages (Isaacs et al.. 1996).
3'
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Figure 1.6 The structure of a generic FGF protein
There are four translation initiation sites (three CUGs and one AUG),
sites of post-translational modification, and a conserved core region
thai contains receptor-binding sites. The scale in amino aerds is
indicated (adapted from Szebenyi & Fallon, 1999).
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The FGF system has multiple functions in early development including
mesoderm formation, gastrulation movements and anteroposterior patterning
(Slack et aI., 1996; Song & Slack, 1996; Isaacs, 1997).
Mesoderm induction by FGFs has been demonstrated in vitro. FGF-1-6,
FGF·9 and eFGF mimic the activity of the presumptive endoderm (vegetal pole)
and induce animal cap elongation and the expression of mesodermal markers in
vitro (reviewed in Isaacs at af., 1997). In addition, FGF overexpression has been
shown to suppress anterior development (reviewed in Isaacs, 1997) and a
dominant-negative FGFR inhibits the formation of posterior and lateral mesoderm
and disrupts the normal dorsoventral pattern (Amaya et af., 1991). As mentioned
previously, the type of mesoderm" induced by FGFs is concentration dependent
and, in vivo, FGFs such as FGF-2 and eFGF are probably involved in mesoderm
patterning rather than mesoderm induction. As described previously, FGFs are
thought to act in synergy with molecules such as BMP-4 and WNT genes as
ventralizing factors that pattem the mesoderm and give rise to ventral
mesodermal derivatives (Gotoh & Nishida, 1996).
The results of disrupting FGF signalling pathways by either its
overexpression or its inhibition are quite striking. DisnJption of fgfr1 results in
severe growth retardation and severely misshapen embryos, which often die at
gastrula stages. Expression of a dominant-negative FGF receptor (XFD) inhibits
mesoderm formation in animal caps and causes defects in trunk and posterior
development in embryos (Amaya at 81., 1991; Kessler & Melton, 1994).
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FGFs are also involved in patterning events, which will not be discussed
further here, occurring later in development such as neural induction and
patterning of the brain, and patterning of the limbs; Szebenyi & Fallon (1999) and
Powers at a/., (2000) provide recent reviews of these activities.
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1.6 FGF receptors
FGFs bind to at teast three distinct types of receptors: fibroblast growth
factor receptors (FGFRs), heparan sUlphate proteoglycans (HSPGs), and a
cysteine-rich FGF receptor (CFR) (reviewed in Szebenyi and Fallon, 1999).
FGFRs are receptor tyrosine kinases (RTKs), which are required for most
biological activities of FGFs; H$PGs are low-affinity receptors for FGFs, which
alter or modulate FGF·FGFR interactions, and CFR participates in FGF
intracellular transport (reviewed in $zebenyi & Fallon, 1999).
The diverse activities exhibited by the FGF family reflect a complex
process involving potential interactions between multiple FGFs, FGFRs and the
side chains of H$PGs (Faham at al., 1998).
HSPGs have been traditionally classified as low-affinity receptors for
FGFs. FGFs bind to the extracellular matrix of target tissues by interacting with
heparan sulfates and related proteoglycans. H$PGs are sulphated
glycosaminoglycans covalently bound to a core protein (reviewed in Szebanyi &
Fallon, 1999). A number of roles have been proposed for proteoglycans in FGF·
mediated cellular response: protection from prQteolysis, localization, and storage
and internalization of FGFs (reviewed in Taipale & Keski·Oja, 1997). FGF-
stimulated signal transduction involves the dimerization of FGFR and it is
probable that H$PGs participate in this process through a direct interaction with
FGFR (Ken at al., 1993; Kan at al., 1996) and/or through oligomerization of FGFs
(Omitz at al.• 1992; Mach at al., 1993; Spivak-Kroizman at al., 1994; Thompson
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et al., 1994). It is thought that H$PGs are important for sustained cellular
response to FGFs. This idea is supported by FGF-induced gene expression
studies, which have shown that FGF·1 can activate early response genes in the
absence of exogenous heparin, but that H$PGs are required for sustained
cellular responses (Donohue et a/., 1997). HSPGs have also been shown to
protect FGF·2 from degradation in the cell matrix; this protection is most probably
an important component in ensuring sustained cellular responses (Donohue et
al., 1997; V10davsky st 8f., 1996; Yeoman, 1993). The H$PGs implicated in
FGF action include syndecans, glypican, and perlecan (reviewed in Szebenyi &
Fallon, 1999). FGFs may require different HSPGs with distinct
glycosaminoglycans for their activities; for example, glypican has been shown to
promote the mitogenic activity of FGF·2, but inhibits responses to FGF·7
(Bonneh·Barkay et al., 1997). Therefore, HSPGs have been proposed as factors
that regulate specific FGF·FGFR interaction and determine which biological
activity prevails (Szebenyi & Fallon, 1999).
CFR is a 150·160 kDa single transmembrane protein that has an
extracellular region with 16 cysteine·rich repeats and a short intracellular tail.
FGF binding to CFR and to FGFRs is mutually exclusive, suggesting that the
binding sites in FGFs for these two receptors are overlapping, and CFR may
regulate intracellular FGF levels and signalling through FGFR by competing with
the latter for FGFs (Zhou at a/., 1997). CFRs may be involved in intracellular
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trafficking and targeting of FGFs but their function and interaction with FGFs
have not yet been fully characterized (Szebenyi & Fallon, 1999).
FGF-stimulated signal transduction involves its binding to the FGFR and
dimerization of the receptor. FGFRs are members of the RTK superiamity
(reviewed in Omitz, 2000), which also includes other receptors such as platelet-
derived growth factor (PDGF) receptor, apidermal growth factor (EGF) receptor,
and insulin growth factor (IGF) receptor (Heldin & Westermark, 1989). There are
four known FGFR genes, FGFR-1, -2, -3, -4, which have an overall similar
structural organization (Figure 1.7). The extracellular domain (Ee) contains two
(11 and Hl) or three (I, II, III) immunoglobulin {lg)-like domains, followed by the
transmembrane (TM) stretch, the juxtamembrane (JM) domain, the kinase
domain (KD) interrupted by a short kinase insert, and a carboxy tail that has
several potential autophosphorylation sites; all these regions interact with
intracellular substrates (reviewed in Szenbenyi & Fallon, 1999). The FGF-
binding site is contained within a 139 amino acid region that includes parts of the
Ig-2 and 19-3 loops (Wang, 1995). Ligand selectivity is detennined by 19-3 loop
(OmitZ £It 8/.,1996). The 19-1 loop is the least conserved region in the FGFR and
regulates binding affinity to different FGFs (Szebenyi & Fallon, 1999). Recent
reviews of the structure and function of these different domains are provided in
Klint & Claesson-Welsh (1999); Szebenyi & Fallon (1999) and Powers £It 81.,
(2000).
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Alternative splicing of the FGF receptor mRNAs generate several different
variants of the receptors, some of which have distinct ligand-binding and
signalling properties (reviewed in Johnson and Williams, 1993; Szebenyi &
Fallon, 1999). The genomic sequence of the third immunoglobulin·like loop of
FGFR-1 to -3 contains two alternative exons (lIIb and lIIe) for the second half of
the third Ig-like loop (Figure 1.7) (reviewed in Klint & Claesson-Welsh, 1999).
Different FGF family members will activate the receptor subtypes to different
extents depending on their abilities to bind with high affinity to each receptor type
(Table 1.2) (Ornitz at 8/., 1996). This explains the ability of a large number of
FGFs to generate different cell specific responses through a somewhat limited
number of receptors (Table 1.2).
Mutations in FGFR1, FGFR2, and FGFR3 can cause different congenital,
autosomal dominant disorders affecting the craniofacial (craniosyntosis) and
sketal (chondrodysplasias) development (Hertz et at, 2001).
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Figure 1.7 The structure of a generic FGFR protein. The major structural features of
FGFRs, an acidic box, CAM binding domain, heparin-binding region, Ig
toops, transmembrane, juxtamembrane, kinase, and kinase insert regions,
are indicated by different colour codes and the three Ig loops are labelled.
Ig loop 3 is alternatively spliced in FGFR 1-3 but not FGFR-4 yielding B or
C splice variants that differ in their ligand-binding properties.
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Table 1.2 FGF signalling through high-affinity FGFR isoforms (adapted from POYIerS et aJ., 2000)
FGF FGFR
FGF·1 FGFR·'.llIb& lIIe; FGFR-2, Illb & ll1e; FGFR-3, IIlb & 1l1c, FGFR-4
FGF-2 FGFR-1, IIlb & lIle; FGFR-2, lIIe; FGFR-3, lIIe: FGFR-4
FGF-3 FGFR-1, IIIb: FGFR-2, IIlb
FGF-4 FGFR-1-lHe; FGFR-2, 11Ie, FGFR-3, lIIe; FGFR-4
FGF-5 FGFR1-lIIe; FGFR-2,Ulc
FGF-6 FGFR1-lIle; FGFR·2,lIlc; FGFR-4
FGF-7 FGFR-2,lIIb
FGF-8 FGFR-1; FGFR-2, IIle, FGFR-3.11lc-, FGFR-4
FGF-9 FGFR-2, IlIe: FGFR-3, IIlb & lIle; FGFR-4
FGF-10 FGFR-1, IIlb; FGFR-2, IIIb
FGF-15 Unknown
FGFs 16-19 FGFR·1,1IlC; FGFR-2, lIIe
FGF-20 Unknown
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1.7 FGF signalling pathways
Ligand binding to receptors initiates signal transduction cascades which
propagate the signals and result in the activation of molecules downstream in the
cascade. FGF signal transduction cascades are initiated by the binding of FGF
to its cell surtace FGFR. The activated receptor then undergoes dimerization
and autophosphorylation on tyrosines within the dimer. Phosphorylated tyrosine
residues recruit other signalling molecules, such as proteins containing src-
homology (SH2) domains and phosphotyrosine-binding domains (PTB), to the
activated receptors (reviewed in Klint & Claesson-Welsh, 1999). SH2 domain
proteins may be substrates for receptor-mediated phosphorylation themselves or
may, as is the case for PTB proteins, function as adaptor proteins to recruit other
target proteins and hence propagate the signal through many signal transduction
pathways (Pawson, 1995).
Although the signal transduction cascades initiated by FGF within
activated cells have yet to be fully elucidated, FGFs have been shown to activate
several well-known cascades such as the phospholipase C y (PLCy) pathway,
the mitogen activated protein kinase (MAPK) pathway, and the phosphoinositide
3' knase (PI3'K) pathway (reviews by HaYt1<ins et 81., 1997; Kamat & Carpenter,
1997; Powers et al., 2000; Szebenyi & Fallon, 1999). These transduction
cascades are initiated by the autophosphorylation of the FGFRs. It should be
noted that mitogenic response has been observed in cells in which receptor
transphosphorylation is much reduced (Krufka et 8f., 1996) and that some FGFs
4.
have nuclear localization sequences, so that FGFs may also have signalling
pathways that are distinct from those activated on the cell surface (Szabenyi &
Fallon, 1999)
The next three sections will briefly review the three main pathways.
1.7.1 The Phospholipase Cr Pathway
PLCy is a signal transduction enzyme which, when activated, initiates
hydrolysis of phosphatidylinositol 4,5-biphosphata to diacylglycerol (DAG) and
phosphatidylinositol 3 (IP3). DAG is an activator of protein kinase C (PKC), a
serine--threonine kinase, and IP3 initiates CaZ+ release from intracellular stores.
Second messengers like PKC and Ca2~ activate several molecules including
transcription factors and thereby result in desired cellular responses such as
transcripUon (reViewed by Kamat & Carpenter, 1997).
PLCy has been identified as being phosphorylated and associated with
FGFR following ligand-dependent activation (Burgess st a/., 1990; Gillespie st
a/., 1992; Ryan & Gillespie, 1994; Ryan et al., 1998) by the binding of its SH2
domain to the phosphorylated Tyr766 of FGFR·1 (Mohammadi at af., 1991).
However, although mutation of the phosphorylated tyrosine residue to
phenylalanine demonstrated that phosphatidylinositol hydrolysis was disrupted
(Mohammadi at sf., 1992; Peters st a/., 1992), the mutation did not affect FGFR-
mediated mitogenesis, neuronal differentiation (Spivak-Kroizman st al., 1994), or
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mesoderm·induction in Xfflnopus animal caps (Muslin at 81., 1994). II has been
shown that activation of protein kinase C (PKC) alone, a downstream effector of
the PLCy pathway, is not sufficient to induce mesoderm in animal cap explants,
although activated PKC has been detected in FGF-treated explants (Gillespie et
al., 1992). This implies that either PLCy is redundant with respect to mitogenesis
and differentiation or that the PLCy pathway is important for other functions of
FGFR signalling (Powers et 81., 2000). It has been suggested that the activation
of PKC during mesoderm activation could be part of a negative feedback
mechanism on the FGF mesoderm induction pathway (Gillespie et aI., 1992).
1.7.2 The Phosphoinositide 3' Kinase Pathway
PI3'K, which phosphorylates the inositol ring at the 3' position and thereby
activates inert membrane phospholipids and initiates a signal transduction
pathway, has been found to be involved in signal transduction of most, if not all,
tyrosine kinases (reviewed in Hawkins et 8/., 1997). The PI3'K pathway is
involved in many systems, including: cytoskeletal rearrangements, cellular
migrations, mitogenesis, differentiation, and protection from apoptosis (reviewed
by Vanhaesebroeck at 8f., 1997; Wymann and Pirola, 1998; Leevers et 81.,
1999).
FGF receptors lack optimal binding motifs for PI3'K, and FGF-induced
PI3'K activity is difficult to detect in vitro as well as in vivo (Kanda et af., 1996;
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van Weering et al., 1998). However, PI3'K activity has been implicated in both
migration and mitogenesis stimulated by a range of other growth factors, and
since FGFs are capable of transducing both these responses, it is quite possible
that PI3'K initiates some of these responses in FGf-mediated signal transduction
(Klint and Claesson-Welsh, 1999). Activated PI3'K has been shown to be
associated with the FGFR during mesoderm induction (Ryan & Gillespie, 1994;
Ryan et al., 1998). Recent work. has shown that PI3'K acts downstream of Ras
and in parallel to the MAPK pathway (described in next section) in the fGf
pathway during Xenopus mesoderm induction (Carballada et al., 2001). Using
natural and synthetic inhibitors of P13'K, the authors found that PI3'K catalytic
activity is required for the definition of trunk mesoderm in the FGF signalling
pathway.
1.7.3 The RAS/MAPK Pathway
SUbsequent to receptor autophosphorylation, SH2 (src homology) domain
containing proteins and phosphotyrosine-binding domain (PTB) docking proteins
bind to specific phosphotyrosines (reviewed in Szebenyi & Fallon, 1999). Some
of the docking molecules for different FGFRs are distinct; for example, SHC and
FRS2 function as docking molecules for FGfR1 whereas FGfR4 was shown to
associate with a p85 serine kinase, and the activated fGfR3-GRB2-S0S
complex contains either a novel 66~kDa protein or SHC (reviewed in Szebenyi &
Fallon,1999). The RASIMAPK pathway is propagated through the recruitment of
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SH2 domain proteins and PTB domain molecules to the activated FGFR
receptor, 'Docking molecules such as FRS2 bind to the phosphorylated receptor
and recruit the GRB2-S0S complex. GRB2 can also dock directly on the
phosphorylated receptors through its SH2 (Src homology 2 domain, which binds
to phosphorylated tyrosines). GRB2 contains SH3 (Src homology-3) domains
that allow it to bind to 'S guanine nucleotide exchange factor (GNEF) such as
SOS. This puts SOS in dose vicinity with RAS, which is membrane bound. SOS
promotes the dissociation of GDP from RAS, allowing the protein to bind a GTP
molecule and to become activated (reviewed in Ferell, 1996).
The activated membrane-associated RAS then recruits RAF-1, a serine·
threonine MAPK kinase kinase (MAPKKK). In tum, RAF·1 activates MAPKK
(MEK), which activates MAPK. MAPK phosphorylates transcription factors such
as JUN, FOS, and the ribosomal S6 kinase. In addition to nuclear substrates,
MAPK has been found to phosphorylate cytosketal proteins, phospholipase, and
protein kinases (reviewed in Ferall, 1996). The RAS/MAPK pathway has been
associated with a number of different FGFR-mediated cell responses such as cell
proliferation, cell responses during gastrulation, migration of certain cell types in
Drosophila, and activation of the urokinase plasminogen activator, cell motility,
and mesoderm formation in Xenopus embryos (reviewed in Szebenyi & Fallon,
1999).
Activated forms of MAPK have been shown to induce the expression of
the mesodermal marker Xbra in animal caps (LaBonne at a/., 1995). The
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RASlMAPK pathway has been shown to be necessary for FGF signalling during
mesoderm induction using a MAPK·specific phosphatase, which blocked the
FGF-mediated formation of mesoderm in animal cap explants (Gotoh at 81.,
1995; LaBonne at al., 1995). Embryos lacking ventral type mesoderm were
produced and were similar in phenotype to embryos overexpressing a dominant
negative FGFR, XFD. which ablates FGF signalling in the embryo (Gotoh at 8/.,
1995; LaBonne at al.. 1995; Amaya at 8/., 1991). These results directly implicate
the RAStMAPK pathway in FGF signalling during mesoderm induction.
The MAPK family consists of five distinct groups of related kinases: A. the
TEY MAP kinases (include the well studied p42JEr1<:2 MAP kinase and p44/Er1<:1
MAP kinase), B. the Hog1fTGY group, C. the JnkfSAP kinase group, D. the
Smk1 group, and E. the Er1<:3 group (reviewed in Ferell, 1996). The different
groups have been implicated in biological processes such as mitogenesis, cell
fate determination. differentiation and induction (reViewed in Ferell,1996).
The RAS/MAPK pathway is well characterized in FGF/FGFR cell
signalling, but it is becoming clear thaI there are several proteins acting in
parallel with RAS, RAF and MAPK. For example. PKC and PKA can also
activate RAF (revieWed in Szebenyi & Fallon, 1999). Several mammalian
isoforms of MAPK and parallel MAPK pathways have been found (FeraH. 1996).
There is also some evidence of crosstalk between the RASIMAPK pathway and
other pathways such as the phosphoinositide (PI) cycle during mesoderm
induction in Xenopus (Rose & Busa. 1998). Stimulation of the PI cycle in
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explants in the absence of growth factors does not induce mesodenn. However,
PI cycle stimulation during treatment of explants with FGF·2 has been shown to
increase MAPK activity and potentiate FGF-2-induced expression of the
mesodermal mar1<er, Xbra (Rose & Busa, 1998). These results suggest that the
PI cycle may be acting synergistically with the MAPK pathway during mesoderm
induction.
In Xenopus, the FGF family seems to be responsible for the full pattern of
activated MAPK in early development (Christen and Slack, 1999). LaBonne and
Whitman (1997) showed that the presence of activated MAPK, or phosphorylated
MAPK, is abolished by XFD injection during early gastrula stages. MAPK
activation first starts at stage 8 in Xenopus embryos, and XFD has been shown
to abolish activated MAPK staining until tailbud stages whereas eFGF activates
MAPK only in embryos (Christen and Slack, 1999).
The staining pattern of activated MAPK during embryonic development
has been characterized. At stage 7, activated MAPK is not visible in embryos.
Activated MAPK is first seen as a dorsal patch in stage 8 embryos in the region
of the future blastopore. At stage 10.5, activated MAPK is present around the
blastopore and at neurula stages is expressed strongly around the blastoporal
ring and in the forebrain, the midbrain/hindbrain junction, dorsal midline and on
either side of the neural plate. At tailbud stages, MAPK is active in the tailbud,
brachial arch, otic vesicle, stomodeal anlage, forebrain and midbrain junction,
heart anlagen and dorsal region of the cement-gland (Christen and Slack, 1999).
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This staining pattem is indicative of regions of active FGF signalling during
mesodermal and posterior patteming in Xenopus (Christen and Slack, 1999).
1,8 FGF Target Genes
FGF treatment result in changes in the steady-state levels of many
different mRNAs. Some of the targets of the FGF signalling pathway during
mesodermal and posterior patterning have been identified. It has been shown
that FGF is involved in the maintenance of Xbra expression in mesoderm
precursor cells (Smith at a/., 1991b). Xbra and eFGF have been shO'Nn to be the
components of an autoregulatory loop in which Xbra induces aFGF expression,
which in tum maintains Xbra expression (Isaacs at al., 1994; Schulte-Merker and
Smith, 1995). FGF signals also regulate the expression of the caudal gene
family member Xcad3 (Northrop and Kimmelman, 1994; Pownall at al., 1996),
which has a critical function in the regulation of posterior hox genes (Isaacs et 8f.,
1998). It has been shown that krox20 and Hoxb9 expression is induced in
explants following FGFR1 activation (Umbhauer at al., 2000). FGF-regulated
genes also include: homeobox genes, patteming genes, growth factors and their
receptors, skeletal muscle regulatory factors, matrix proteins, protesses, and
protease activators and inhibitors (Szebenyi & Fallon, 1999)
While the list of FGF-modulated genes is still incomplete, it supports the
hypothesis that FGFs have a broad and diverse range of action and affect the
expression and function of many diverse groups of proteins. It should be noted
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that not all these FGF regulated proteins are expressed at the same time and in
the same cet! type, although many of them have been observed be to activated
simultaneously or sequentially, Furthermore, FGFs have been shown to act
either synergistically or antagonistically with other growth factors such as
members of the TGF-13 family, insulin-like growth factor (IGF), and members of
the wingless family (WNT) (reviewed in Szebenyi & Fallon, 1999).
The next section will focus on one class of FGF target genes, the
immediate-early genes.
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1.8.1 Growth factor-induced immediate~arlygenes
The first genes to be transcribed in response to growth factor treatment of
a cellular population are known as immediate-early genes (or earty response
genes). Immediate-earty genes have also been described as the set of genes
linked directly to receptors by transduction mechanisms and include those that
are expressed when a cell is stimulated to leave the Ga phase of the cell cycle
and enter Gt (reviewed in Thomson at a/., 1999).
To be classified as immediate--earty, a gene must be transcribed without
de novo protein synthesis and depend solely on factors already present in the
cell to enable a quick response, and is usually expressed within thirty minutes of
mitogen activation (Thomson at 81., 1999). Some immediate-early genes, such
as members of the c-fos and c-jun families, are characterized by their rapid and
transient expression in response to extracellular stimuli. In addition,
phosphorylation of a number of transcription factors and two chromatin-
associated proteins, HMG·14 (high mobility group-14) and histone H3, is tightly
correlated to immediate-earfy gene induction (Mahadevan at 81., 1991; Barratt at
al., 1994a; Barratt at 81., 1994b; Hazzalin at 8/., 1996). ImmediatEHlarly gene
response is elicited by three broad classes of biochemical, physical and
pharmacological stimuli: (i) polypeptide growth factors such as epidermal growth
factor (EGF), FGF, platelet derived growth factor (PDGF) and cytokines; (ii)
stresses such UV radiation and heat shock; and (iii) pharmacological compounds
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such as 12-Q-tetradecanoylphorbol 13-acetate (TPA), okadaic acid and
anisomysin compounds (revie'Ned in Thomson et al., 1999).
Thus, transcriptional activation of immediate-earty genes, such as
transcription factors, is the first response to the signal transduction pathways
initiated by growth factors. In tum, the transcription factors initiate (or terminate)
transcription of new genes, which are or are not subsequently translated into
proteins. The absence or presence of the latter ultimately carry out the desired
cellular response.
To date, only occasional immediate--early FGF response genes have been
identified and characterized. One well..characterized FGF immediate-early
response gene is the Xenopus homologue of the Brachyury gene, Xbra.
Expression of Xbra is an immediate-early response to mesoderm induction by
FGF (Smith et al., 1991). Xbra is able to induce mesoderm formation: ventral
mesoderm at IO'N concentrations and intermediate mesoderm at higher
concentrations (Cuncliffe and Smith, 1994). Furthermore, as mentioned
previously, Xbra has been shown to activate transcription of eFGF in an
autocatalytic manner during mesoderm induction (Isaacs et al., 1994).
1.9 Isolation and cloning of eM
Our lab recently identified a novel transcript, early-response gene 1 (er1),
whose expression levels increased in Xenopus embryo explants during
mesoderm induction by FGF-2 (Paterno et al., 1997).
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As described in Paterno et al., (1997), ert was identified through the peR·
based differential display method (liang & Pardee, 1992) in an attempt to identify
and charaderize genes that are expressed during earty cellular response to FGF.
A Xenopus blastula library (Gillespie at aI., 1995) was used to obtain the full
sequence of ert eDNA, which is 2.3 kb, and consists of a 1497-base pair single
open reading frame predicted to encode a protein of 493 amino acid residues.
Expression of ert mRNA peaks during the late blastula stage of Xenopus
(Paterno et 81., 1997).
The steady-state levels of ert were shown to increase 3-4 fold upon
treatment with FGF. However, this increase in erl levels was not due to de
novo protein synthesis because cycloheximide (an inhibitor of protein synthesis)
did not affed the FGF·jnduced increase in art lavels. These results effectively
showed that er1 is an immediate--earty gene (Paterno at al., 1997).
A database homology search revealed three regions 01 similarity in the
predicted ER1 amino acid sequence to rat and human proteins encoded by the
metastasis-associated gene, mta1, and two regions of similarity to the
Caenot1Jabditis alegans saquence that has similarity to mla1 (Paterno at a/.,
1997). However, ert is not the Xanopus homolog of mta1, since a human
homolog of arl has been found that is distinct from human mts1 (Paterno at al.,
1997; Paterno at al., 1998).
The expression of rat mta1 has been associated with metastatic
phenotypes (Toh at 81., 1994). Human ert is expressed in breast-carcinoma cell
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lines and breast tumour tissue 'Nhile being undetectable in normal tumour ceO
lines and tumour tissue suggesting that en expression is associated with the
neoplastic state in human breast carcinoma (Paterno et al.. 1998). Figure 1.8A
shows amino acid homology between Xenopus ER1 and rat and human MTA 1
and figure 1.88 shows the amino acid homology between Xenopus and human
ER1.
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Figure 1.8 Amino acid homology between ERI and MTAI and Xenopus and human
ERI
A. Homology between Xenopus ER I and C. elegom, rat and human MTA I
B. Homology between Xenupus and human ER 1
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lysis of the ER1 amino acid sequence revealed four regions that contain
putative nuclear localization signals (NLSs) (Paterno at al., 1997; Post at al.,
2001) These are 13aRPRRCK1<43 (NLS1), 261RRLR26<4 (NLS2),
32oKKSERYDFFAOQTRFGKKK338 (NLS3) and <463RPIKRQRMDSPGKm (NLS4)
(Post et al., 2001), NLS4, which contains a core region ~RPIKRORNIMD<471)
similar to the core NLS directing c-MYC to the nucleus, has been found to be the
only bona fide NLS necessary and sufficient for targeting ER1 to the nucleus
(Post at af., 2001). Of the other putative three NLSs, only NLS1 has been shown
to function only as a weak NLS (Post etaf., 2001).
A proline-rich sequence corresponding to the PXXP motif found in all high
affinity SH3 (src homology 3) ligands was identified near the C terminus. The N
terminus of ER1 contains four highly acidic regions, characteristic of the acidic
activation domain of many transcription factors (Patemo at aI" 1997). There is
also a highly conserved region in the middle region of ER1 (amino acid 287-349),
the SANT domain (Paterno at al., 1998). Tha SANT domain is a motif with
potential transcription and chromatin-related functions initially found in ~3,
8da2, the co-repressor McaR, and IFIIB, and conserved in a number of
transcription factors and oncogenes such as mta1 and members of the myb
family of oncogenes (Aasland et ai" 1996). Although the function of the SANT
motif is itself unclear, SANT homologous repeats in the Myb oncoprotein have
been implicated in DNA binding (Howe at af., 1990; Ogata at al., 1994). Recent
reports have indicated that a SANT-containing region of several co-repressors
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can bind (You at al., 2001; Guenther at al., 2001) and activate (Guenther at al.,
2001) histone deacetylases, indicating a chromatin-related role. Analysis of the
amino acid sequences of both ER1 and MTA1 has revealed that the similarity
between ER1 and MTA1 lies in the SANT domain (Paterno et a/., 1998). Another
conserved region, ELM2 (EGl·27 and MTA1 homology2), has been found in
ER1 (amino acid 169-229) (Solari at al., 1999). As discussed in Solari et aI.,
(1999), the ElM2 region is not similar to any domains of known function but is
present in many proteins containing the $ANT domain including MTA1.
Figure 1.9 shows a schematic of the putative functional domains in ER1.
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Figure 1.9 A schematic showing putative functional domains in ER1
There are four regions of acidic amino acids in the N-terminal region. The ELM2
region is found in the middle of the protein and the SANT domain is found in the
C-terminal region. There is a PXXP motif in the C-terminal region and two NLSs.
The NLS in the N-terminus functions as a weak NLS and the NLS in the C-
terminus has been found to be the bona fide NLS that is sufficient for targeting
ER1 to the nucleus (Post et al., 2001).
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1.10 Purpose of this study
At the time this study was undertaken, er1 was a newly cloned gene
whose expression pattern and function were unknown. The purpose of this study
was to characterize the expression and function of ER1 protein during early
development of Xenopus and gain an insight into its function.
Objective 1: Characterization of the expression pattern of ER1 protein
during earty development in Xenopus
The mRNA levels of a gene give a good indication of the expression of
transcripts, but ultimately it is the expression of the protein products of the gene
that are most useful in determining the tissues and time frame of the expression
of a particular gene. The spatio-temporal expression pattern of proteins is critical
to understanding their function. At the start of this project, Northern blotting had
given us an indication of the levels of er1 transcripts during early development. It
was shown that er1 was a maternal transcript, whose steady-state levels were
relatively constant during early cleavage stages, increased 2-foId at blastula
stages, and then decreased 6-fold during gastrula, neurula and tailbud stages
and remained below detection level during subsequent development (Paterno at
al., 1997). The first objective of this project was therefore to characterize the
expression pattern of ER1 protein during early developmental stages in Xenopus
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Objective 2: Identification of mechanisms regulating the expression of ER1.
Spatio-temporally restricted expression pattern is a characteristic of many
genes that are expressed during early development, and is often an indication of
a distinct and defined role in embryogenesis. The mechanisms that regulate the
differential expression of these genes often vary. Resolving the processes that
regUlate the expression of a gene is often crucial to determining their function in
a biological system. Once the expression pattem of ER1 protein was
characterized, the second objective was to determine how this expression
pattern was regulated during development.
Objective 3: Characterization of the function of ER1.
Analysis of the DNA sequence of genes gives clues to the function of the
protein products of these genes. At the start of this project, computer assisted
analysis of the DNA sequence of eri had identified several domains, including
stretches of acidic amino-acid residues, nuclear localization signals, and protein-
protein interaction domains (Paterno et al., 1997). Identification of these
domains, as well as characterization of the expression pattern of ER1 (Objective
1), helped design experiments to determine the function of ER1. A common
strategy used when working with new genes, like eri, whose functions are
unknown, is to use the information present in the DNA sequence to identify
putative function. The third objective of this project was to characterize the
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Objective 4:
function of ER1 using in vitro assays involving deletion constructs of putative
functional domains of ER1.
Characterize the function of ER1 during early development
in Xenopus
A common technique used to elucidate the function of genes and gene
products in developmental studies is to misregulate their expression by
overexpressing or inhibiting them in vivo. In embryological studies, cRNA is
injected in newly fertilized embryos and their development is followed to detect
morphological abnormalities. By misregulating the expression of a gene, and
studying the effects of this misregulation, one can attempt to define the normal
function of the gene and its product. The fourth objective of this project was to
characterize the function of ER1 in embryos by studying the effects of ER1
overexpression.
67
SECTION II ER1 IS DIFFERENTIALLY LOCALIZED TO
NUCLEI DURING EARLY DEVELOPMENT IN
XENOPUS EMBRYOS
CHAPTER 2 CHARACTERIZATION OF THE EXPRESSION
PATTERN OF ER1 DURING EARLY
DEVELOPMENT IN XENOPUS EMBRYOS
Note: Part of chapter 2 was previously published in Luchman et 81., (1999)
2.1 INTRODUCTION
There is little or no transcription during early cleavage stages in amphibian
development. As a result, earty embryos depend on proteins translated from
maternally inherited mRNAs (transcribed during oogenesis and stored in the
maternal cytoplasm) and on maternal proteins (which are already present in the
egg) for the numerous cellular processes that take place in the embryo before
the onset of zygotic transcription (Seydoux, 1996). Maternal mRNAs and
proteins provide essential factors for growth and cell viability and regulate
embryonic polarity and cell fate. It is critical, therefore, to regulate precisely the
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accumulation of both matemal proteins and of the proteins translated from
maternal mRNAs after fertilization as a means of regulating their function
(Seydoux, 1996). The expression pattern of a protein is the gateway to
understanding its function during development.
en is a Xenopus immediate-Early response gene, cloned in our
laboratory, whose expression is activated by FGF~2 (Paterno et al., 1997).
was shown that en is a maternally derived message whose expression is
restricted to stages prior to mid-gastrula. The first objective for this study was to
characterize the expression pattern of ER1 protein during early development.
Western blotting, whole-mount staining and immunocytochemistry techniques
were used.
2.2 MATERIALS AND METHODS
2.2.1 In vitro fertilization of mature Xenopus oocytes
Female Xenopus frogs (Nasca) were induced to ovulate with a
subcutaneous injection in the dorsal_side in the upper portion of one of the hind
legs towards the cloaca with 400·500 I.U. (0.4-o.5ml) of HeG (Sigma-Aldrich)
and left at room temperature (RT) for 12-14 hours until they started to ovulate.
A male frog (Nasca) was sacrificed by a subcutaneous injection in the
dorsal side in one of the hind legs with a lethal dose of the anaesthetic
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Methanesulfonate (MS222, Sigma-Aldrich) and the testes were removed. The
testes were cleaned by rinsing in 1 times Normal Amphibian Medium (1xNAM;
110mM NaCI (BDH), 2mM KCI (Fisher Scientific), 1mM Ca(N03~.4H20 (Fisher
Scientific), 1mM MgSO".7H20 (Fisher Scientific), 0.1mM EDTA pH 8.0 (Fisher
Scientific), 10mM HEPES (Fisher Scientific), pH 7.5, 1mM NaHC(h (Fisher
Scientific), and 12.5mg Gentamycin (Sigma-Aldrich) in dH20) and stored at 4°C
in 1xNAM.
Before fertilization, a small portion of testes was macerated in a drop of
distilled water (dH~) and the released sperm were examined under a compound
microscope for viability. Eggs were squeezed from an ovulating female into a
100x15mm Fisher brand disposable petri dish. A small portion of testes was
rinsed in dH20 and macerated in fresh dH20 before being pipetted on the eggs.
The eggs and sperm were mixed by rocking gently for a few seconds and left at
RT for 5 minutes to allow fertilization to take place. The eggs were flooded with
dH20 to dilute the sperm mixture. After 15 minutes, successfully fertilized eggs
rotated so the dark pigmented side of wild-type eggs was on top. Albino eggs
were also left for 15 minutes to rotate. The dH20 was poured off and 2.0%
Cysteine-HCL (Sigma-Aldrich) in dH~, pH 7.8-8.1, was added to the embryos,
the mixture was transferred to a 250 ml glass beaker and shaken for a few
minutes to remove the jelly coat from the embryos. Once the outer jelly coat was
removed, eggs became close packed. Dejellying was stopped by gently diluting
the embryo-cysteine mixture with dH20 and rinsing with at least five changes of
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dH20 and two changes of NAM120 (NAMI20; 5.5mM NaC!. O.1mM KCI, O.05mM
Ca(NO:)h.4H20, O.05mM MgS04.7H20, 0.005mM EDTA pH 8.0, 0.5mM HEPES
pH 7.5, 0.05mM NaHC03; 1.25mg Gentamycin in dH20). Embryos were cultured
in NAMl20 at RT, 14°C or 18·200C, and staged according to Nieuwkoop and
Faber (1967).
2.2,2 Western blot analysis of ER1 protein at different embryonic stages
Extracts from embryos at different developmental stages (stage 2, 6.5, 8, 8.5, 10,
13, 27, and 45) were prepared for Western blotting by homogenizing whole embryos
in iee-cold solubilization buffer (1% Triton-X100 (Fisher Scientific), 10mM Tris-CI
(Fisher Scientific), pH 7.5, 10mM EDTA, plus protease inhibitors: 1mM PMSF
(Sigma-Aldrich), 25 Ilglml aprotinin (Sigma-Aldrich), 25 j.1g1ml leupeptin (Sigma-
Aldrich), and 5 ....g/ml TlCK (Sigma·Aldrich) in dH20). Ten embryos were processed
per treatment. After 30-min solubilization at 4°C, the samples were centrifuged at 10
OOOg for 5 min. The clear middle layer was removed with a 1ml syringe leaving the
bottom pellet of insoluble material and the top lipid layer behind. The process was
repeated if the middle layer was cloudy. The extracts were vortexed with an equal
volume of Freon (Sigma·Aldrich) to separate yolk proteins from the other soluble
proteins and the upper aqueous layer was removed. Total protein was precipitated
out of the aqueous layer with 100% acetone at _20° C for 25 min and centrifuged at
10 ooOg for 20 min. The pellet was washed once by vortexing with ice-cold 70%
acetone and centrifuging for 20 min. The pellet was air-dried for 5 min and
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resuspended in sample buffer [50mM Tris pH 6.8, 2%Sodium dodecyl sulfate (50S)
(Fischer SCientific), and 800mM beta~Mercapto Ethanol (BME) (Bio-Rad
Laboratories) in dH20j. Protein measurements were performed using the Bio-Rad
protein assay (Bio-Rad laboratories), to ensure equal loading of protein.
The samples were subjected to 50S-PAGE through 8% polyacrylamide gels,
followed by Western blotting onto HybondTM~ECL nitrocellulose membranes
(Amersham Pharmacia Biotech). Bio-Rad prestained molecular weight standards
(12.5 J.lgllane) (Bio-Rad laboratories) were included on each gel. The blots were
blocked for 1 hour with 5% non-fat milk powder in TB5~T buffer (20mM Tris, pH 7.6,
137mM NaCI, and 0.1% (liN) Tween·20 (Bio-Rad) in dH20) plus 0.02% sodium
azide) and stained with anti·ER1 antiserum at a 1:1000 dilution in TBS-T (Paterno et
at, 1997) overnight at RT. The blots were washed with four changes of 100ml TBS~
T over a one-hour period followed by a one-hour incubation with a 1:3000 dilution of
a 1mg/ml HRP-labelled goat anti-rabbit secondary antibody (lnllitrogen Life
Technologies Inc.) in TBS~T. The wash step was repeated. The detection step was
perfonned using the ECl system (Amersham Pharmacia Biotech), as per
manufacturer's directions. The experiments were repeated three times.
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2.2.2 Embryo staging, sectioning, and ER1 immunocytochemistry and
nuclear and antibody staining of embryos
Albino Xenopus laevis embryos were obtained as described above and
staged according to Nieuwkoop and Faber (1967). Antibody staining of whole-
mount embryos, immunocytochemistry and nuclear staining of sectioned
embryos was perfonned according to the procedure described by Harland (1991)
with some modifications. Ten embryos at each different developmental stage
(stage 6.5, 8, 8.5, 10, 13, 27, and 45) were fixed for one hour with rotation in
freshly prepared MEMFA (100 mM MOPS (Fisher Scientific), 2mM EGTA (Fisher
Scientific), 1mM MgS04 • and 0.37% formaldehyde (Fisher Scientific) in dH20) at
RT. The fixed embryos were stored in 100% Methanol at _20°C until required for
staining. Embryos were bleached under white light for one hour in bleaching
solution (1:3 (vlv) of 30% H20 2 and two parts Dent's fixative (20% dimethyl
sulfoxide (DMSO) (Sigma-Aidrich), 80% methanol». Bleaching decreases
pigmentation and optimizes visualization of the stain. The bleaching solution was
replaced with maleic acid buffer (MAS; 100 mM maleic acid (Sigma-Aldrich) and
150mM NaCI in H20, pH 7.5). The embryos were washed with three changes of
MAB and placed into an 8 well polystyrene (Costar) insert dish. The embryos
were incubated on a rotator for one hour in blocking buffer (2% (w/v) blocking
reagent toT nucleic acid hybridiZation and detection (8MB) (Boehringer
Manheim), 5% (vlv) DMSO, 5 % (vlv) heat-inactivated goat serum (Invitrogen Life
Technologies Inc.,) and 0.02% (vlv) sodium azide (Sigma-Aldrich) in MAB) at RT.
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The blocking buffer was replaced with a 1:200 dilution of anti-ER1 antibody
(Patamo at at, 1997) in blocking buffer. The embryos were incubated overnight
on a rotator at 4°C after which they were washed with MAS every 30 minutes for
6 hours. The embryos were then incubated with a 1:200 dilution of an alkaline
phosphatase-coupled goat-anti-rabbit secondary antibody (Invitrogen Life
Technologies, Inc.) in blocking buffer and the embryos were rotated at 4°C
overnight. The following day, the embryos were washed as before followed by
two 5 min washes with alkaline phosphatase (AP) buffer (100mM Tris, pH 9.5,
5mM MgClz (Fisher Scientific), 100mM NaCI, 0.5% (vlv) Tween-20, and 5mM
Levamisole (Sigma·Aldrich) in dHzO). Embryos were stained with a mix of 4-nitro
blue tetrazolium chloride (NBT; 33.75 mg/ml; Boeringher Manheim) and X·
phosphate/5-brom0-4-chloro-3-indoyl-phosphate (BCIP; 17.5 mg/ml; Boeringher
Manheim) in AP buffer until a dark purple colour developed. The staining reaction
was stopped by removing the staining solution and replacing it with MEMFA. The
stained embryos were kept at 4°C. For long-tenn storage, the embryos were
kept in MAS plus 0.02% sodium azide at 4°C. The experiment was repeated
three times.
For sectioning, ten embryos at each of stage 6.5; 8, 8.5, 10, 13,27, and 45 were
fIXed in MEMFA and stored in 100% methanol at 4°C. Polyester wax (PEG 400
distereate, A1drige Chem Co.) and embedding moulds were wanned at 40°C in a
water bath a few hours before use. Embryos were transferred to 100% ethanol then
transferred into moulds in a 1:1 ethanol:wax solution and some of the ethanol wax
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solution was removed and replaced by fresh molten wax. This was repeated several
times over one hour to allow the wax to penetrate. The mould containing the
embryo and wax was removed from the water bath and cooled to RT, a mould
holder was placed on top of the mould while the wax was still molten. The embryo
was oriented in the wax using two forceps until the wax solidified. The' wax was
allowed to harden at RT for 2-3 hours after which the moulds were kept at 4°C. All
sectioning instruments were cooled at _20°C for 5 minutes before sectioning. The
block of wax was carefully removed from the mould and trimmed to expose the
embryo. The holder was placed in a microtome, 8~ sections were made, and
sections were collected on gelatin subbed glass slides. A solution of 0.1% Triton-
X100 in dH20 was carefully pipetted on the slides to spread the sections, after which
the solution was removed and the slides left to air dry at RT. The sections were de-
waxed using a 100%, 95%, 80%, 75%, 50%, 30% ethanol rehydration series in MAS
and a MAS rinse). Antibody staining was pel10rmed as for whole mount staining
except slides were incubated in small plastic boxes and washes were pel10rmed in
Coplin jars. Nuclear staining was pel10rmed by incubating the slides in a 1:500
dilution of a liv~J1 nucleic acid stain (Molecular Probes). The experiment was
repeated three times.
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2.3 RESULTS
Northem blotting by Patemo at a1. (1997) had previously shown that ert
mRNA is expressed as a single message, which is detectable during earty
cleavage stages prior to the onset of zygotic transcription, Densitometric
analysis showed that er1 levels stay constant dUring these early cleavage
stages, increase slightly at blastula and decrease during gastrula, neurula and
tailbud stages. This pattern of expression indicates that er1 is a maternally
derived RNA, since the mRNA is present in the embryo before the onset of
zygotic transcription at mid-blastula stages.
Although mRNA expression gives an idea of the expression pattern of a
gene, it does not atways give an accurate picture of the spatio-temporal
expression pattern of a protein since amphibian embryos often contain maternal
stores of protein as well as mRNA. Some maternal mRNAs, such as CRM1,
have been shown to be under negative translational control during early
development in Xenopus (Kudo et aI., 1997). Other maternal RNAs, such as
x1gv7/xlcaax~1, have been shown to be redundant during early development
When the store of xlgv7lx1caax-1 maternal RNA is depleted through antisense
technology, the embryos still develop normally due to the presence of a maternal
storeofxlcaax~1 protein (Reddy etal., 1991a, 1991b).
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The spatio-temporal expression pattern of ER1 protein was therefore
examined in order to get a better indication of the tissues in which ER1 was
functional.
2.3.1 The expression level of ER1 protein is constant during early
developmental stages in Xenopus
The expression pattern of ER1 protein was analysed by Western blotting
during stages similar to those examined by Paterno at 81., (1997) for RNA
expression by Northern blotting. Stages 2, 6.5. 8. 8.5, 10. 13, 27 and 36 were
examined. The Western blot revealed that ER1 protein is detectable and that
expression levels are similar for all stages examined; staining pattern for stages
6.5, 8, 8.5, and 10 are shown in Fig. 2.1
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Stage: 6.5 8 8.5 10 6.5 8 8.5 10
Antibody: Pre Immune
200-
106-
80-
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1 2 6 7
Figure 2.1 ER1 protein is expressed during early development
Embryo extracts from stages 6.5 (lanes 1 and 5), B (lanes 2 and 6),
8.5 (lanes 3 and 7) and 10 (Janes 4 and 8) were subjected to $DS-
PAGE, blotted and stained with anti·EA1 (lanes 5 and 8). The blot
was stripped and re-stained with pre-immune serum (lanes 1-4).
The position of ER1 is indicated on the right and the molecular
weight standards are on the left.
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2.3.2 ER1 Is differentlalty localized to the nucleus during earty embryonic
development
In embryo whole-mounts and sections stained with anti-ER1 antiserum,
the first detectable staining is observed in the nucleus of marginal zone cells
(presumptive mesoderm) of stage 8 blastula (Figs. 2.2 and 2.3), even though
equivalent levels of ER1 protein are present at earlier stages (stage 6.5, Fig.
2.1). ThUS, ER1 protein is present in the cells of the early stage embryo but does
not become concentrated in the nucleus until mid-blastula stage.
No staining was observed at stage 6.5 using preimmune or anti·ER1
serum, (Fig. 2A and B, respectively). As development proceeds, more nuclei
become stained and by late blastula (stage 8.5-9), virtually aU nuclei in the animal
hemisphere are stained (Fig. 2.1E,F). At this stage, the nuclei in the vegetal
hemisphere begin to stain and by early gastrula (stage 10) ubiquitous nuclear
staining is observed (Fig. 2.4). The same trend was observed for neurula stages.
During tailbud stages, endodermal and mesodermal tissues retain their
nuclear staining (Fig. 2.5B, E, F); however, in ectodermally-derived tissues, such
as the brain and epidermis, nuclear staining begins to disappear (Fig 2.5e, D).
This pattern of decreasing concentration of ER1 in the nucleus of various tissues
continues throughout late development and by tadpole stage; nuclear staining is
observed only in some endodermal nuclei (Fig 2.6A, B). At tadpole stage of
development, nuclear staining is no longer detected in any ectodermally or
mesodennaliy-derived tissue (Fig. 2.68-0), however, cytoplasmic staining is
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observed in some mesodermal tissues (Fig. 2.68-0). Neural tissue is not stained
except for weak cytoplasmic staining in the eye (Fig. 2.6B. C).
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Figure 2.2 Localization of ER1 to the nucleus begins during blastula stages.
Albino embryos were fixed at stages 6.5 (A,S), 8 (C,D) or 8.5 (E,F) and
stained with either pre-immune serum (A, C, E) or anti·EA1 (8, 0, F). Nuclear
staining (see arrows in D) first appears in the marginal zone cells (presumptive
mesoderm) of stage 8 blastulae; by stage 8.5 (one additional cell division), virtually
all nuclei in the animal hemisphere are stained (F). The animal hemisphere of the
embryo is shown facing up. Bar = 0.1 mm.
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Figure 2.3 ER1 is concentrated in the nucleus of marginal zone cells in stage 8
blastulae.
Embryos were fixed at stages 6.5 (A) or 8 (&D), sectioned and stained with
anti-ER1. (A) The nuclei (arrows) remained unstained in early cleavage stages.
(8-0) At stage 8, the nuclei (arrowheads in B and arrow in D) in the marginal
zone begin to stain for ER1 while nuclei in the endoderm (B) as well as nudei
(arrows in C) in the rest of the animal hemisphere remained unstained. An =
animal hemisphere. Veg = vegetal hemisphere. Bars = 0.1 mm in A, B
and 0.02 mm In C, D.
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Figure 2.4 ER1 is concentrated in the nucleus of all cells in stage 10 gastrulae.
Embryos were fixed at stage 10, sectioned and stained with either pre-immune
(A) or anti-ER1 (B). at stage 10, ER1 is concentrated in the nucleus in virtually
aU cells of the three germ layers; the arrowhead indicates the involuting lip; ar,
archenteron; ble, blastocoel. An = animal hemisphere, Vag = vegetal hemisphere
8ar5=0.1 mm
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fig 2.S ERI begins to disappear from the oucleus in tbe epidermis and bf1lin during
tanbudstages.
Embryos were fixed at stage 27, sectioned and stained with either preimmune (A)
or anti-ERI (B-f). At stage 27, nuclei are stained in the endodenn (B), somites
(arrows in B and E), notochord (arrows in F). as well as in most ofthe spinal cord
(tailed arrows in F). Many of the nuclei in the brain (tailed arrows in B-D) and
epidermis (arro....'S in C, O) are no longer Slained, as iJIustraled by comparing the
anti-ERI stained epidermis and brain in (C) with the same section incubated with
a fluorescent nuclear stain (D). The black arrows in (C) mark the position of me
nuclei identified by white arrows in D. Bars s 0.1 mm.
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Figure 2.6 ER1 is no longer concentrated in the nucleus in stage 41 tadpoles
Embryos were fixed at stage 41, sectioned and stained with either preimmune (A)
or anti-ER1 (B-D). At stage 41, staining is absent from neural tissue (8) except for
weak cytoplasmic staining in the eye (C). Staining in mesodermal tissues is
exclusively cytoplasmic and is observed in 50mites (tailed arrows in B and C).
Nuclear staining is also absent in the epidermis (tailed black arrows in C) but is still
observed in some of the endodermal cells (tailed arrows in B). Bars = 0.1 mm.
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2.4 DISCUSSION
Analysis of the protein expression levels of ER1 during early
developmental stages showed that, unlike the mRNA levels, the expression level
of ER1 protein remained constant for all stages examined (Figure 2.1). ER1
protein is expressed at constant levels at stages when the mRNA levels go up
(Figure 2.1 lanes 6 & 7, blastula stages) or are very low or undetectable (Figure
2.1 lane 8, gastrula; neurula and tailbud stages not shown). Although it was not
possible to determine whether the ER1 protein detected on the Western blot was
the product of maternal mRNA translated during early development and/or was
matemal protein already present in the egg, it was clear that ER1 protein is
present in the embryo from early cleavage stages at detectable and constant
levels.
There are several mechanisms, which could be potentially involved in
maintaining constant ER1 expression levels throughout the developmental
stages examined: 1. The protein may be longer-lived than the maternal mRNA.
since the protein is detectable at stages when the mRNA levels decrease; 2. The
protein may be very efficiently translated from low levels of mRNA during the
later developmental stages 3. The embryo may have a store of matemal ER1
protein as well a.s en mRNA, and the protein detected on the Western blot could
be from either or both sources.
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There are examples of other proteins with similar protein expression
patterns to that of ER1. An example is OCT1/POU, a maternally derived
transcriptional activator in Xenopus, where the protein is at a constant level
during early development and persists until neurula stages after downregulation
of the mRNA (Veenstra et aI., 1995; Veenstra at aI., 1999). As discussed
previously in this thesis, mRNA expression and localization during early
development do not always give an accurate picture of the expression and
distribution of the protein.
Many studies use RNA in situ hybridization techniques to visualize the
tissues in which a gene is being actively transcribed. In the case of Xenopus
embryos, maternal RNA is transcribed during oogenesis and localized to different
parts of the egg, where it is in a stable form and is translated at different stages
after fertilization. Localization of RNA during oogenesis is a means of regulating
the translation of the protein to a specific embryo region and hence spatially
regulating expression of the protein. However, mRNA is not always
translationally active in regions where it is localized (Seydoux, 1996). For
example, Xwnt~11 mRNA is symmetrically distributed in the vegetal region of the
early Xenopus embryo, but Xwnt·11 protein is asymmetrically distributed along
the dorso-ventral axis of the embryo, where it probably acts as a dorsa-ventral
determinant during establishment of the dorso-ventral axis (Schroeder at at,
1999).
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Therefore, ER1 protein whole·mount antibody staining was used to
visualize the spatia-temporal localization pattern during early cleavage and later
developmental stages. During earty blastula stages, ER1 is found in the
cytoplasm (as shown by Western blotting, Figure 2.1) and is gradually localized
to nuclei at mid- and late-blastula stages. The staining in the cytoplasm at early
blastula stages is weak (almost similar to pre-immune staining). However, at
these stages, the cytoplasm/nuclei ratio in the embryos is quite high, since the
cells are very large. The staining is much darker at later stages when ER1 is
localized to nuclei, as the protein spread over a large cell becomes confined to a
smaller cytoplasm and a comparatively small nucleus. Although ER1 protein is
present during earty cleavage stages, nuclear localization only starts at mid-
blastula stages. The spatia-temporal localization pattern of ER1 indicates that
nuclear translocation of the protein is regulated during earty development.
Appropriate subcellular localization is crucial for the proper functioning of
proteins. Cytoplasmic localization is a way of regulating the functions of proteins
including DNA replication, transcription and nuclear transport There are several
examples of proteins whose functions are regulated by spatia-temporal
localization in Xenopus. For example, the Xnf·7 protein product, a maternally
expressed putative transcription factor, is cytoplasmic during early cleavage
stages in the Xenopus embryo and enters embryonic nuclei at mid-blastula
transition (Dreyer and Hausen, 1983; Miller et al., 1989; Kloc et al., 1989; Reddy
et 81., 1991b). Ultimately Xnf-7 becomes enriched in the nuclei of the cells of the
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central nelVOUS system at larval stages of development (Miller et al.. 1989).
OCT-1. a transcription activator in Xenopus, is also cytoplasmic until mid-blastula
stages after which it gradually translocates to nuclei and is highly abundant in the
nuclei of cells of ectodermal lineages during gastrulation (Veenstra et aI., 1995).
CCAAT, a matemal fact~r, which activates GATA-2 transcription in Xenopus, is
localized within the cytoplasm of the embryo, until the beginning of gastrulation,
when it becomes specifically translocated to the nucleus as zygotic GATA-2
transcription begins (Brewer et at, 1995). CRM1IXP01, a protein involved in the
specific export of proteins and RNA from the nucleus, is initially present in the
cytoplasm of embryos in an inactive form, and becomes functional during the
gastrula-neurula transition after which it becomes localized to the nuclear
membrane (KUdo et 81.. 1997).
The stUdy of processes involved in the regulation of the localization of
ER1 to the nucleus will be described in chapter 3.
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SECTION II ER1 IS DIFFERENTIALLY LOCALIZED
DURING EARLY DEVELOPMENT IN
XENOPUS EMBRYOS
CHAPTER 3 INVESTIGATION OF THE MECHANISM/S
REGULATING NUCLEAR LOCALIZATION OF
ER1 DURING EMBRYONIC DEVELOPMENT IN
XENOPUS
Note: Part of this chapter has been submitted for pUblication.
3.1 INTRODUCTION
Numerous proteins have been identified in Xenopus whose subcellular
localization is developmentally regulated (Dreyer, 1987). The germinal vesicle
(GV) accumulates a reserve of maternal RNA and proteins, which are required in
the early developmental stages of the embryo such as enzymes and precursors
for DNA synthesis, chromatin assembly, nuclear formation and transcription
(AJmouzni and Wolffe, 1993;von Dassow at al., 1993). During oocyte maturation,
the GV disintegrates and its proteins become distributed in the cytoplasm. Some
maternal proteins quickly re-accumulate into nuclei during early cleavage stages
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while others do not re.enter nuclei until blastula and gastl1Jla stages (Dreyer,
1967). Examples of these are: nucleoplasmin, which rapidly migrates to the
nuclei of the cleaving embryo after fertilization (Dreyer, 1967) and small nuclear
ribonucleo proteins (snRNPs), which enter the nuclei only during late blastula
and early gastrula slages (Zeller et al., 1983). Xnf7 and Oct-1 are transcription
factors that are also retained in the cytoplasm until mid-blastula to gastl1Jla
stages (Miller etaf., 1991; Veenstra et 81.,1999).
Different mechanisms in various cells have been identified that regUlate
retention of proteins in the cytoplasm. For example, members of the ReIJNF-KB
family of transcription factors are retained in the cytoplasm through interaction
with an inhibitor that is differentially phosphorylated (reviewed in Karin et aI.,
1999). NF-KB heterodimers usually exist in the cytoplasm as a complex with the
inhibitor IK8 Extracellular stimuli activate signalling pathways leading to
phosphorylation and subsequent proteolysis of IKB, thereby releasing and
enabling translocation to the nucleus of NF-xB heterodimers. In the case of Xnf-
7, a 22-amino acid cytoplasmic retention domain (eRD) functions cooperatively
with two phosphorylation sites within the Xnf-7 molecule to retain the protein in
the cytoplasm (Li et at, 1994)
The developmentally regulated nuclear translocation of ER1 indicates that
there is a tight control on nuclear localization of ER1 during early development.
Regulated nuclear localization is often a means of controlling the function of
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proteins such as transcription factors. Therefore, the controlled nuclear
localization of ER1 during earty Xenopus development may be an important
mechanism in regulating its activity. In this chapter, different regulatory
mechanisms that might control translocation of ER1 protein to the nucleus during
early development in Xenopus laevis were investigated.
3.2 MATERIALS AND METHODS
3.2.1 In vitro transcription of RNAs
Xenopus er1, Xenopus fibroblast growth factor receptor (FGFR1) and
dominant-negative FGFR (XFD, Amaya et aI., 1991) cRNA were prepared from
eDNA templates that had been previously subcloned in the sp64T vector using
the SP6 Ribomax large scale RNA production system (Promega Corporation)
and cap analogue (New England Biolabs, Inc.). The cap analogue is a 7-rnethyl
guanine residue, which is added ooto the 5' terminus of the RNA to increase its
stability and translation efficiency in Xenopus. The er1 and FGFR1 templates
were linearized with the restriction endonuclease Xba1 (Amersham Pharmaeia
Biotech) and the XFD template with EcoR1 (Amersham Pharmacia Biotech). The
following reagents were combined in a 1.5ml eppendorf tube: 10l-l1 SP6
5xTranscription buffer, 2.5J,.l.l each 100mM AT?, CTP and UTP, 1.5jJl 100mM
GTP, 10Jll 30mM cap analogue (New England Biolabs, Inc.), 10J.1.Q of linearized
eDNA template, 5jJ.1 SP6 RNA polymerase enzyme mix and nuclease-free H20 to
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a final volume of 100jil. The mixture was gently pipetted up and down, briefly
centrifug9d and incubated in a 370e water bath for two hours. After incubation,
5U (5~1) of RQ1 RNAse free DNAse (Promega Corporation) was added to
remove the cDNA template, and the reaction mixture was further incubated at
3t'C for 20 minutes. Then 200 ~l of nuclease-free H20 was added and
phenol/chloroform extraction was sequentially performed by addition of equal
volu.mes of buffer-saturated phenol and chloroform. The top aqueous layer
was removed and precipitated ovemight at _20°C with one tenth the initial
volume of 3M sodium acetate (Fisher Scientific), pH 5.2, and 2.5 volumes of
100% ethanol. The cRNA was palleted by centrifuging at 10,000g for 20
minutes. The pellet was washed three times with 70% ethanol and briefly
vacuum dried. The cRNA pallet was resuspended in 501-11 DEPC-treated H20.
To verify the presence of intact cRNA of the right size and the absence of
impurities such as cDNA, 1jiI of the each of the cRNA samples was run on a
0.8% agarose gel. Absorbance was measu~d at 260 and 280nm to determine
concentration, purity and integrity of the cRNA The cRNA samples were stored
at-70°C.
3.2.2 RNA injections
The cRNA was injected into embryos with a Drummond "Nanoinject"
Microinjeetor using 31/2" Drummond glass capillary tubes (Fisher Scientific). The
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needles were previously pulled vertically using a Narishige Model PB-7
micropipette puller and the tips bevelled at a 20° angle with a Narishige EG-40
grinder. For the overexpression studies, albino embryos were injected with 1·
20ng erl cRNA in the animal pole at two-cell stage. Albino embryos were
injected at two-cell stage in both cells with either 1ng en cRNA alone or co-
injected with 10n9 FGFR1 or 10ng XFD, for experiments involving disruption of
the FGF signalling pathway. All experiments were repeated 3·5 times and SO-
100 embryos/experiment were injected. Injection volumes were 4.6nl.
3.2.3 Whole-mount antibody staining
Albino embryos were collected at stage 6.5-7, S.5 and 9 and whole-mount
antibody staining was performed as preViously described (Luchman et at, 1999).
A 1;400 dilution of anti-ER1 antiserum (Paterno at. a/., 1997) and a 1:400 dilution
of alkaline-phosphatase-linked goat-anti-rabbit antibody (Invitrogen life
Technologies, Inc.) was used for staining. At each stage, 10·15 embryos were
stained per experiment, which were repeated 3-5 times.
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3.2.4 a-amanitin treatment and reverse transcriptionlpotymerase chain
reaction (RT/peR)
en cRNA was prepared using the Ribomax large scale RNA production
system (Promega Corporation) as described above. Embryos were injected with
DEPC~treated H20 or en cRNA (4 ng/embryo) plus or minus GC-amanitin (Sigma-
Aldrich) (50IJg/embryo; Newport and Kirshner, 1982 & Sible et al., 1997).
Embryos were processed for whole-mount staining as described above at stage
7,8 and 9. RNA was extracted from stage 8.5 and 10.5 embryos and processed
for RT/PCR as described below.
3.2.4.1 RNA extractfon
Ten whole embryos were transferred to 1.5ml eppendol1 tubes containing
1ml of Tn-Reagent (Invitrogen Life Technologies, Inc.) and homogenized with a
micropipette. RNA extraction was performed as instructed by the manufacturers.
After the reaction, total RNA was re-suspended in 39~t1 of DEPC-treated dH:p.
Remaining traces of DNA were removed by incubating for 20-30 minutes in a 37°
C water bath with O.1U (1JlI) of RNAguard RNase inhibitor (Amersham
Pharmacia Biotech), 5JlI 10X transcription buffer (400mM Tris~HCL, pH 7.5,
60mM MgCI2, 20mM spermidine (Invitrogen Life Technologies Inc.) and 5U (5Jll)
RQ1 RNAse free DNase (Promega Corporation). After incubation, the final
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volume in each tube was adjusted to 100jJ.1 with OEPC·treated dH20 and
phenol/chloroform extracted with equal volumes of buffer·saturated phenol and
water·saturated chloroform. The remaining aqueous layer was precipitated with
2.5 volumes of 100% ethanol and one tenth volume of 3M sodium acetate, pH
5.2 at _200 C ovemight then centrifuged at 40 C for 25 minutes at 10,000g. The
supematants were removed and the pellets were washed with 70% ethanol. The
pellets were briefly vacuum dried, re-suspended in OEPC·treated dH20 and
stored at _700 C. The concentration and integrity of the RNA was examined by
absorbance and by gel electrophoresis.
3.2.4.2 Reverse transcription of isolated RNA
About 200ng of each extracted RNA sample was diluted to a final volume
of 15jJ.1 with OEPC·treated dH20 in 0.5ml Eppendorf tubes. 2jJ.1 of 100ng/ml
random hexanucleotide primers (Boeringher Manheim) was added to each tube,
after which the RNA was denatured at 70° C for 10 minutes and placed
immediately in an ice bath to prevent intemal pairing of RNA strands and allow
annealing of the primers to the RNA. To each tUbe, a reverse transcription
mixture consisting of 8jJ.1 first strand buffer (Invitrogen life Technologies Inc.), 8jJ.1
of 2.5mM deoxyribonucleotide triphosphates (dNTPs, Amersham Pharmacia
Biotech), 4jJ.1 100mM on (Invitrogen life Technologies Inc.), 1 jJ.1 RNAguard
RNAse inhibitor (Amersham Pharmacia Biotech) and 2jJ.1 M-MLV reverse
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transcriptase (Invitrogen Life Technologies Inc,) was added. The reaction
mixtures were incubated at 3r C for one hour after which the resulting eDNA
samples were kept frozen at _200 C,
3.2.4.2 peR of reverse transcribed products
A premix was prepared for PCR amplification reactions (10mg/ml 10xPCR
buffer (Invitrogen Life Technologies Inc.), 1.5mM MgCI2 (Invitrogen Life
Technologies inc.), O.8mM dNTPs (Amersham Phamacia Biotech), 2ng/mt each
primer of 1 set of specific primers (Oligos Etc.), 0.02 U/J.l1 platinum Taq DNA
polymerase (Invitrogen Life Technologies Inc.), and 50 jJ.Curieslml [32p)ATP
(Amersham Pharmacia Biotech) in dH20), Histone H4, was used as an internal
control with 5'-eGGGATAACAnCAGGGTATCACT-3' and 5'-
ATCCATGGCGGTAACTGTCTTCCT-3' as forward and reverse primers. EF1-a::
was amplified using 5'-CCTGAATCACCCAGGCCAGATTGGTG-3' and 5'·
GAGGGTAGTCTGAGAAGCTCTCCACG-3', In O.5ml thin·walled eppendorf
tubes (Fisher Scientific), 48j.l.1 of the master mix was added to 2J.l1 of reversed
transcribed eDNA. The reaction mixtures were vortexed briefly and 50j.iJ of light
mineral oil (Fisher Scientific) was added to the top of the mixtures to prevent
evaporation during thermocycling. A Perkin Elmer Thermal Cycler was used for
the thermocycling reactions. The [32P)ATP·labelled PCR products were analyzed
in the linear range for amplification, using the following program:
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1 cycle: 94°C, 5 minutes for activation of enzyme
'x' cycles: 55°C, 1 minute for annealing of primers
72°C, 1 minute for primer extension
94°C, 1 minute for denaturation
1cycle: 55°C, 1 minute for annealing of primers
72°C, 7 minutes for primer extension.
'x' was empirically determined to be 22 cycles for Histone and 24 cycles for EF1-
<:c. The PCR products were examined by a 6% polyacrylamide/6M urea gel
electrophoresis and autoradiography.
3.2.5 lmmunoprecipitatlon and Western Blotting
Extracts from embryos at different stages were prepared for Western
blotting as described in Chapter 2, except 50 mM sodium pyrophosphate, 50 mM
sodium fluoride. and 1mM sodium vanadate were added to the extraction buffer
to prevent dephosphorylation. Extracts were immunoprecipitated with a 1:50
dilution of anti-ER1 antiserum (Paterno et. aI, 1997) overnight at 4°C, 50 ,.u of
Protein-A-Sepharose (Amersham Pharmacia Biotech) was added and the
mixture was rotated at 4 °c for one hour. The Sepharose protein was wash~
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three times with 1ml extraction buffer plus phosphatase inhibitors and twice with
1ml 150mM NaC!. To each sample, 35 ~I of sample buffer (50mM Tris pH 6.8,
2% sodium dodecyl sulfate (SOS) (Fischer Scientific) was added and the
samples were boiled for 4 minutes. The protein was resolved on an 8%
acrylamide gel and transferred to a nitrocellulose membrane (Hybond ECl,
Amersham Pharmacia Biotech). The membranes were stained with a 1:1000
dilution of biotin-conjugated anti-phosphotyrosine (Upstate Biotechnology, Inc.),
anti-phosphoserine (Sigma-Aldrich) or anti-phosphothreonine (Sigma-Aldrich).
Detection of ER1 protein was performed by loading 150 ~g of total embryo
extract for uninjected embryos or 7.5 ~g total embryo extract for er1·injected
embryos and staining with a 1:5000 dilution of ER1 antiserum. The Femtolucent
system (Chemicon Intemational, Inc.) was used for chemiluminescence
detection. To compare expression levels of ER1 in H20·injected and er1 cRNA
injected embryos, densitometric analysis was performed using a Canberra·
Packard Chemilmager.
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3.3 RESULTS
Several possible mechanisms were investigated in order to characterize
the localization of ER1 to the nudeus.
3.3.1 ER1 Is localization to the nucleus does not require zygotic
transcription
The localization of ER1 to the nucleus appear to coincide with the start of
zygotic transcription at mid-blastula stages. The possibility that targeting of ER1
to the nucleus was dependent on protein(s) translated from zygotic message(s)
was therefore examined. Zygotic transcription was inhibited to determine jf
nuclear translocation is dependent on newly transcribed gene products.
Xenopus embryos were injected with or without a-amanitin, an inhibitor
of RNA polymerases II and Ill, and/or with er1 cRNA. Co-injection was provide
high concentrations of ER1 and a-amanltin at the same site. Subcellular
localization of ER1 antibody staining was examined at several stages in whole-
mount antibody preparations (Fig. 3.1). In both er1-injected and er1/a-amanitin
injected embryos, ER1 remained cytoplasmic at stage 7 (Fig. 3.1A &.6), was first
found in the nuclei (see arrowheads in Fig. 3.1C & 0) at stage 8 and became
nuclear at stage 9 (Fig. 3.1E & F). Thus, no difference was detected in the
subcellular localization pattern of ER1 in er1-injected compared to er1/a-amanitin
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co-injected embryos, and both pattems were the same as that of endogenous
ER1, previously described (Luchman at al. 1999)
To verify that (l~amanitin was effective in blocking zygotic transcription, the
expression levels of elongation factor 1~o:: (EF1·o::) was examined by ~p.
radiolabelling using RT·PCR (Fig. 3.2). EF1·o:: is a maternal gene whose
expression level increases dramatically through zygotic transcription (Krieg at al.,
1989). Our results show that the expression level of EF1-o:: increases
significantly in post-MBT embryos (Fig. 3.2, lanes 1 and 4; 2 and 5), but not in a~
amanitin-injected embryos (Fig. 3.2, lanes 3 and 6).
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Figure 3.1 Translocation of ER1 to the nucleus is not dependent on zygotic
transcription.
Fertilized embryos were injected with 4n9 e,1 cRNA plus (+) or minus (-)
a-amanitin as descibed under "Materials and Methods~ and cultured until
they reached stage 6.5-7, 8 or 9. Whole mount staining was performed as
described under "Malerials and Methods", Nuclear staining first appears at
stage 8 (red arrowheads B and D). A total of 10-15 embryos per stage were stained
for each experiment and the experiment was repeated three times. Embryos
were photographed with the animal hemisphere facing up. Scale bar, 0.1 rom.
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Figure 3.2 The expression of zygotic EF1-a is blocked bya-amanitin.
Total RNA (8 embryos per condition) was extracted at blastula (lanes
1-3) or gastrula stages (lanes 4-6) from DEPC-H20 injected (lanes 1
and 4), ert cRNA injected (lanes 2 and 5) or ert plus a~amanitin
injected (lanes 3 and 6) embryos and analyzed by 32P-labelled RT-PCR
as described under "Materials and Methods". The positions of EF1-a and
Histone H4 PCR products are indicated on the right.
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3.3.2 Overexpressed ER1 is localized In the nucleus
The second possibility investigated was that ER1 is retained in the
cytoplasm through its association with an inhibitor or anchor protein, as is the
case for NF-kB (reviewed in Karin, 1999) and Xnf-7 (Li at 81.,1994), respectively.
Inhibitor proteins mask the nuclear localization signals and prevent nudear
localization; for example, h::B associates with NFkB and prevents it from
localizing to the nucleus (reviewed in Karin, 1999) Other proteins such as Xnf-7
have a cytoplasmic retention domain through which it associates with a
cytoplasmic protein, and is anchored and retained in the cytoplasm (Li et al.,
1997). ER1 protein was overexpressed to titrate any possible protein causing
retention of ER1 in the cytoplasm.
Embryos were injected with 1-20n9 of er1 cRNA and ER1 protein was
visualized by whole-mount antibody staining at stage 6.5, 8 and 9 (Figure 3.1A,
C, and E, shows staining pattern of embryos injected with 4n9 of er1 cRNA). The
staining pattern in the overexpressed embryos (Figure 3.1A, C, and E) was the
same as for endogenous ER1 (Fig. 2.2, B, D and F). ER1 remained cytoplasmic
at stage 7, (Fig. 3.1A), was first found in the nuclei, (arrowheads in Fig. 3.1C), at
stage 8, and became nuclear at stage 9, (Fig. 3.1E). This pattern was also
observed when higher concentrations were injected. As can be seen in Fig.
3.3A(1I), injection of as much as 20n9 of en cRNA did not lead to premature
translocation of ER1 to the nucleus at stage 6.5, a stage where endogenous ER1
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is exclusively cytoplasmic (Luchman et al., 1999). Injection of 20ng of er1 cRNA
did not affect localization of ER1 to the nucleus at stages 8 and 9, the pattern of
nuclear localization was the same as for endogenous ER1. That ER1 was indeed
overexpressed in these embryos was verified by Western blot (Fig. 3.38). Using
densitometric analysis, the level of ER1 in injected embryos was determined to
be in vast excess over endogenous ER1, at approximately 1DO-fold.
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Figure 3.3 Overexpression of ER1 does not lead to premature targeting
to the nucleus
(A) Fertilized embryos were injected with either CEPe H20 (I) or 20 n9
ef1 cRNA (II), fixed at stage 6.5 and stained by whole mount staining as
described under· Materials and Methods". (B) ER1 protein was collected
from DEPc-.H20 injected (0) and erl cRNA injected (+) embryos; Western
blotting with anti·ER1 was pertormed as described (Luchman at al.• 1999).
Due to the high levels of ER1 protein in the er1-injected embryos, only 7.5
~g of total embryo extract was loaded (lane 2), while 150 ~g of extract from
CEPe-H2o injected embryos was loaded (Ianel). Scale bar, 0.1 rom.
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3.3.4 XFD injections disrupts nuclear localization of ER1
Given that en transcription is activated in response to FGF (Paterno at aI.,
1997), a possible connection between nuclear localization of ER1 and the FGF
signalling was investigated. The FGF signalling pathway was disrupted by co-
expressing a dominant-negative FGF receptor, XFD, with ER1 in order to
determine jf nuclear translocation of ER1 was dependent on the FGF signalling.
Embryos were injected with 1ng of erl cRNA alone or co-injected with
either. 1-10ng of wild-type Xenopus FGFR1 cRNA, or 1-10ng of the dominant-
negative receptor, XFD, cRNA. Wholemount staining for ER1 was per10rmed at
stage 9 since we had previously shown that, in the animal hemisphere, ER1 was
exclusively nuclear at this stage (Luchman et al., 1999). Embryos were also
scored morphologically. Embryos injected with XFD cRNA had truncations in the
trunk and posterior region as previously reported by Amaya et a/., (1991). In
embryos expressing both ER1 and XFD, a significant proportion of the cells
around the injection site exhibited cytoplasmic staining at aU concentrations of
co-injected XFD. Fig. 3AA shows the pattern obtained when the highest
concentration of XFD, 10ng, is co-injected with erl. In cells co-expressing wild-
type FGFR1 and ER1, on the other hand, staining was exclusively nuclear, even
when 10ng of wild-type FGFR1 was co-injected with erl (Fig. 3.48); the latter
was similar to the staining pattern of cells expressing ER1 alone (Fig. 3AC) as
well as to the pattem of endogenous ER1 staining previousty described
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(luchman et al., 1999). These results suggest that, nuclear translocation of ER1
is dependent on events triggered by FGF signalling.
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Figure 3.4 Nuclear translocation of EA1 Is dependent on FGF signalling
Fertilized embryos were Injected with 1ng ar1 cRNA alone (C) or with 10ng
XFD (A) or FGFA (8) as described under "Materials and Methods' and cultured
until they reached stage 9. Whole mount staining was periormed as described
under "Materials and Methods". At the bottom of each panel, a magnified view of
the injection site in the embryo on the left is shown. Examples 01 cytoplasmic
staining are indicated by arrowheads and nuclear staining by arrows. A total of
10-15 embryos per stage were stained for each experiment and the experiment was
repeated five times. Embryos were photographed with the animal hemisphere facing
up. Scale bar, 0.5 mm (white) 0.2 mm (black).
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3.3.5 Different phosphorylated proteins are associated with cytoplasmic
and nuclear ER1 \
Signal transduction cascades initiate events such as protein-protein
interactions, protein phosphorylation and protein dephosphorylation.
Furthermore, retention of nuclear proteins in the cytoplasm is often regulated by
phosphorylation (Dreyer, 1987). Differential phosphorylation was therefore
examined as a potential mechanism for the regulation of ER1 targeting to the
nucleus.
Embryo extracts were immunoprecipitated with anti-ER1 antibody at
stages when ER1 is either predominantly cytoplasmic (Reynolds et at, 1996) or
predominantly nuclear (Ryan and Gillespie, 1994). Western blots were stained
with anti-phosphotyrosine, anti-phosphothreonine, anti-phosphoserine or anti-
ER1. Staining with anti-ER1 resulted in detection of a single band, with no
evidence of additional slower migrating bands that might represent
phosphorylated forms (Fig. 3.5, 'lane 3). This is consistent with our previous
findings that ER1 was present as a single band at all developmental stages
examin6d (Luchman £It al., 1999). In addition, ER1 did not co-migrate with any of
the observed phosphoprotein bands (Fig. 3.5, lanes 1-6). Taken together, these
results indicate that ER1 is not itself phosphorylated.
Staining with anti-phosphothreonine did not reveal any reproducible bands
(results not shown), while staining with anti-phosphotyrosine and anti-
phosphoserine revealed several bands co-precipitating with ER1 (Fig. 3.5, lanes
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1-2, 4·5). Of the two phosphotyrosine bands detected, neither exhibited
differences in intensity between stage 7 and 9 (Fig. 3.5, lanes 1 and 2).
Four phosphoserine bands (Fig. 3.5, arrowheads) of calculated molecular
weight 226, 118, 76 and 38 kDa were detected and a significant decrease in the
level of the latter three were detected at stage 9 when compared to stage 7 (Fig.
3.5, lanes 4-5). The 226 kDa band, on the other hand displayed little difference
in intensity between the two stages. The identity of these phosphoserylproteins
is presently unknown; therefore, I cannot measure their expression level to
determine whether the differences in band intensity are due to changes in the
amount of associated protein or due to changes in the level of phosphorylation.
Interestingly, stage 9 embryos injected with XFD did not display these changes
(Fig. 3.5, lane 6), but rather retained the phosphoserine pattern seen at stage 7,
in which ER1 is retained in the cytoplasm (Fig. 3.5, compare lanes 6 and 4
respectively).
1I3
---
Figure 3.5 Changes in ER1-associated phophoserylproteins during early development
are correlated with ER1 nuclear translocation.
Embryo extracts (150 embryos/sample) were obtained from stage 7 (lanes
1 and 4) and stage 9 (lanes 2 and 5) embryos and from stage 9 embryos
injected wi1h XFD cRNA (lane 6). Immunoprecipitation and Western blotting
were performed as described in "Materials and Methods", The Western blot
was stained with anti-phosphotyrosine (lanes 1,2) and antiphosphoserine
(lanes 4-6). For comparison, total embryo extract was loaded in lane 3 and
stained with anti-ER1. The arrowheads indicate the four phosphoserine bands
while the square bracket indicates the heavy chain of IgG. The positions of the
molecular size markers is indicated on the right.
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3.4 DISCUSSION
ER1 translocates to the nucleus in NIH 3T3 transfected cells (Paterno at
81., 1997; Post at ai"~ 2001) however, in Xenopus embryos the timing of nuclear
translocation is precisely regulated Therefore, there must be intrinsic
mechanisms present in the embryo, regulating nuclear translocation of ER1
during early development. This may be an important mechanism for regulating
ER1 activity during early development. Elucidation of these regulatory
mechanisms would, therefore, provide clues to the function of ER1 in the
embryo.
Recently, an NLS, 463RPIKRQRM04n, similar to the core FIlLS directing the
human c·MYC protein to the nucleus (Makkerh at af., 1996) was identified near
the C·terminus of ER1. This sequence was found to be necessary and sufficient
for ER1 targeting to the nucleus in NIH 3T3 cells (Post at 8/., 2001). The
presence of a functional NlS in the ER1 sequence oonfinns that the importin
transport machinery has the ability to mediate the localization of ER1 to the
nucleus. However, the presence of an NlS on a protein is not always sufficient
to direct its nuclear import. For example. the NlS may be modified or masked so
that it is no longer recognized by the nuclear transport machinery. Masking the
NlS may be achieved by post·translational modifications such as
phosphorylation or intra- or inter-molecular interactions. The protein is then
sequestered in the cytoplasm until the NlS is unmasked, as is the case for the
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proteins of the NF-KB family. NF-KB heterodimers usually exist in the cytoplasm
as a complex with the inhibitor IKB. Extracellular stimuli activate signalling
pathways leading to phosphorylation and subsequent proteolysis of h,Boc,
thereby releasing NF-KB heterodimers and enabling translocation to the nucleus
(reviewed in Karin at a/.. 1999).
Furthermore, as discussed earlier, an NLS-<:ontaining protein might be
anchored in the cytoplasm by binding another protein as seen for Xnf·7 (Li at aI.,
1994). Cadherins act as anchors for proteins such as p..catenin in the cytoplasm
(reviewed in Ben-Ze'ev, 1999). My overexpression.study attempted to titrate out
any such factor.
Overexpression of ER1 did not result in its nuclear translocation. Although
the possibility that a regUlatory factor(s) is present at high enough concentration
to prevent complete titration cannot be ruled out, the 100-foJd overexpression of
ER1 in injected embryos over uninjected embryos makes it unlikely that at least a
partial titration would not have been observed. These considerations suggest
that translocation of ER1 to the nucleus is not regulated by binding to an inhibitor
or anchor protein and it is hypothesized that nuclear translocation of ER1 is
regulated by another mechanism such as differential phosphorylation or
interaction with a positive regulatory protein. This eventJs may be triggered by a
signalling pathway such as the FGF signalling pathway, which has previously
been shown to activate er1 transcription in Xenopus (Paterno et a/., 1997)
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Nuclear translocation of ER1 does seem to be dependent on events
triggered by the FGF signalling cascade since ER1 remained cytoplasmic in
embryos injected with XFD, a dominant-negative FGFR, which shuts down the
FGF signalling pathway. The pattern of nuclear translocation of ER1 is
consistent with the same spatia-temporal pattern as the FGF signalling pathway
during early development. FGF triggers several signal transduction cascades in
the embryo: both the P13' kinase and the ERK (MAPK) pathways are involved in
mesoderm formation (Carballada et al., 2001). Although some FGFs are
expressed maternally, FGF signalling through MAPK is initiated at blastula
stages (Christen & Slack, 1999). ERK activity is first detected at stage 8 in the
embryo and at gastrula stages ERK is expressed in a ring around the newly
formed mesoderm region in Xenopus embryos (Christen & Slack, 1999). ER1 is
also first seen in nuclei of mesodermal cells at blastula stages (Luchman et 8/.,
1999).
Signal transduction cascades triggered by mitogens often result in events
such as phosphorylation, dephosphorylation or protein-protein interaction and in
tum may initiate nuclear translocation of certain proteins. For example, STATs
are transcription factors that are involved in eliciting transcriptional effects in
response to cytokine signalling. Nuclear translocation of STATs is dependent on
receptor signalling by molecules such as EGF, PDGF or CSF-1, subsequent to
which members of the Janus kinase (JAK) family are recruited to the receptor.
The JAKs phosphorylate the cytoplasmic domains of the tyrosine kinase
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receptors, which in tum recruit $TAT members to the receptor via their SH2
domains. Once the STATs are receptor associated, they are phosphorylated by
the JAKs on their essential tyrosine residues. Following phosphClfy1ation, the
STATs homo- or heterodimerize, and are translocated to the nucleus, where they
can activate transcription (reviewed in Cartwright and Helin, 2000).
Several other proteins have been shown to localize to the nucleus
following stimulation by mitogens. For example, in PC12 cells, the localization of
the transcription factor FnIL-6 (which binds to the serum-response element
(SRE) in the c-fos promoter in response to cAMP) changes following stimulation
of cells with forskolin, which raises intracellular cAMP levels. FNIL-6 is IlOnnatly
located in the cytoplasm of untreated cells but becomes predominantly nuclear
after treatment with forskoHn. This re-distribution correlates with an increased
phosphorylation of FNIL-6 (reviewed in Vandromme at 8/.. 1996).
localization of four proteins involved in gene expression (c-fos and c-myc)
or replication (DNA polymerase a and proliferating cell nuclear antigen (PCNA»)
are subject to significant variation during celt cycle progression. In serum·
starved NIH 3T3 cells, the proteins accumulate in the cytoplasm, whereas serum
stimulation triggers nuclear translocation of c-fos and c-myc, foHowed by PCNA
and DNA polymerase (l (Vriz at 81., 1992). c-fos nuclear translocation is
dependent on continuous stimulation of the celt with mitogens. It was shown that
stimulation of quiescent cells with agents that raise intracellular cAMP levels
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restored the nuclear translocation of c-fos in serum-starved cells (Roux et aI"
1990).
The phosphorylation results for ER1 demonstrate a link between nuclear
translocation and changes in ER1-associated phosphoserylproteins and suggest
that these changes are triggered by FGF signalling.
However, athough Phospho-antibodies provide a relatively simple and fast
way to analyze phosphorylation in vivo, there are some inherent problems which
have to be considered when using these antibodies. Phosphospecific antibodies
do not always detect phosphorylation of certain proteins due to sterie hindrance
of the recognition sites. This is specially true for phosphothreonine and
phosphoserine antibodies Kauffmann et al., 2001). Furthennore, antibodies
against phospho-serine and phospho-threonine are generally not specific enough
to detect one phosphorylated serine or threonine side chain although they are
specific for sequence motifs containing phospho-serine or phospho-threonine.
This is because the epitope presented by a single phosphorylated serine or
threonine side chain is too small (reviewed in Sickmann & Meyer, 2001; Sun at
af., 2001). The use of phospho-specific antibodies can also result in the isolation
of non-phosphorylated species along with the phosphorylated species of interest
(Conrads at al., 2002). Detection of phosphorylation of ER1 or associated
proteins may also have been limited by the relative abundance of the
phosphorylated protein species; low levels of phosphorylated protein may not
have been detected by the antibodies. Therefore, it is possible that, for the
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reasons stated above, the phosphorylation profile of ER1 and proteins
associated with it during nuclear localization has not yet been fully resolved.
Furthennore, the possibility that the aitica1 event triggered by FGF
signalling is interaction with a non-phosphoprotein that 'NOuld thus have not been
detected by the antibodies used cannot be ruled out. The results with oc:-amanitin
suggest that these phosphoserylproteins are not zygotic proteins, but either
maternal proteins or proteins translated from maternal message
The results presented in this chapter suggest that nuclear translocation of
ER1 is regulated by changes in ER1-associated phosphoserylproteins, triggered
by the FGF signalling pathway. in Xenopus embryos.
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SECTION III
CHAPTER 4
INVESTIGATION OF THE FUNCTION OF ER1
ANALYSIS OF PUTATIVE
TRANSACTIVATION FUNCTION DOMAINS
IN ER1 PROTEIN
Note: Part of this chapter was previously published in Patemo at al. (1997). The
results presented here represent solely the thesis author's contribution to the
manuscript
4.1 INTRODUCTION
The N-terminus of ER1 includes several highly acidic stretches (Fig. 1)
characteristic of the acidic activation domains of many transcription factors
(Ptashne, 1988). ER1 also contains a proline-rich sequence near the C-terminus
which corresponds to the PXXP motif found in all high affinity SH3-domain binding
ligands (Cohen at aI., 1995). As previously discussed in this thesis, a nuclear
localization signal (NLS), ~RPIKRaRMDm, found to be necessary and sufficient
for targeting to the nucleus, was identified near the carboxy terminus of ER1 (Post
at aI., 2001). These domains are highly characteristic of transcription factors.
Transcription factors or regulators fall into two classes, those that activate
transcriptioo (activators) and those that inhibit it (repressors). However, it has
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become increasingly dear that there are several factors, that are capable of
performing both these functions (Roberts and Green, 1995). Transcriptional
activation domains, which are better characterized than transcription repression
domains, have been loosely classed according to their amino acid composition
(Hampsey, 1998; Orphanides et a/., 1996; Ptashne & Gann, 1997): regions rich
in acidic amino acids, glutamine, or proline regions and bUlky hydrophobic
residues. Other that these general characteristics, activation domains do not
show apparent sequence conservation (reviewed in Melcher, 2000). Typical
examples of acidic activation domains are the potent activation domains of the
herpes virus VP16 protein and yeast GAl4 protein (Cress & Triezenberg, 1990).
Repression domains are less well characterized than activation domains
(Johnson, 1995; Gashler at 8/., 1993). A few of the known repression domains
are rich in alanine (Licht et aI., 1990), basic amino acids (Baniahmad et al., 1992)
and prolines (Han & Manley, 1993; Ostling et 81.,1996; Madden at af., 1991).
Transcription factors are synthesized in the cytoplasm and must
translocate to the nucleus at some stage in order to potentially activate
transcription. ER1 was shown to localize to the nuclei of Xenopus embryos
during certain developmental stages (chapter 2; Luchman et aI., 1999). In this
chapter, the ability of nuclear ER1 to intrinsically regulate transcription during
Xenopus embryo development was investigated.
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4.2 MATERIALS AND METHODS
4.2.1 Cell culture
NIH 313 cells (American type Culture Collection) wefe grown in tissue
culture medium (13 giL (w/v) Dulbecco's Modified Eagle Medium (DMEM,
Invitrogen), 3.7 gil (wlv) NaHC03, 10% (vlv) calf serum, 50 UlL Penicillin
(Invitrogen Ufe Technologies Inc.), and 50~g/ml Streptomycin (Invitrogen Ufe
Technologies Inc.) in dHzO) at 37 ~C, 10% CO2. Cells were trypsinized (0.025%
(v/v) trypsin (Invitrogen Life Technologies Inc.) in PBS/EDTA (137 mM NaCI
(SOH), 2.7 mM KGI (Fisher Scientific), 1.4 mM KHzPO.. (Fisher Scientific), 8.1
mM NazHPO.." 7H~ (Fisher Scientific), and 1mM EDTA (Fisher Scientific) in
dHzO»), passaged at a 1:5 dilution every three days, and plated into fresh 100
mm tissue culture dishes. Stocks of cells were frozen at -70G e in calf serum plus
10% (v/v) DMSO.
4.2.2 Plasmid construction
The expression vectors used were engineered to oontain various regions
of ERl fused to the GAL4 BD (DNA binding domain) of the pM plasmid
(CLONTECH) a~d are named according to the amino acids of ER1 that each
encodes. Specific primers inoorporating 5' and 3' Bgnl sites (ER 1-493 and ER
176-493) or a 5'EcoR1 and a 3' BamH1 site (ER 1-175 and ER 1-25) were used
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to amplify PCR fragments encoding the appropriate amino acids. The digested
PCR fragments were inserted into the complementary sites of the pM plasmid,
and all plasmids were sequenced to verify the insertion junctions, the en
sequence and the proper reading frame. ER 1-98 and ER 1-57 were generated
by digesting the ER 1·175 construct with Pst! or Pvull respectively, and re-
ligating the largest fragments.
4.2.2 Transient transactivation assays
0.5 Ilg of a chloramphenicol acetyl transferase (CAT) reporter plasmid
(pG5CAT, CLONTECH) was co-transfected into 3 x 10$ cells with 1.0).1g of either
the pM vector alone or one of the pM-en fusion constructs using 12111
LipofectAmine reagent (Invitrogen Life Technologies Inc.) according to
manufacturer's directions. After 48 h, celt extracts were prepared and assayed
for CAT enzyme activity using a CAT enzyme-linked immunosorbent assay kit
(Boehringer Manheim) according to the manufacturer's directions. The amount
of CAT was normalized with the protein concentration.
4.2.3 Immunocytochemistry
For ER1 immunocytochemistry, NIH 3T3 cells were cultured and
transfected with either 1f.19 of pcDNA3 vector (Invitrogen Life Technologies Inc.)
or with 1J.1Q en-pCONA3 using LipofectAmine as described above. Following 24h
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transfection, cells were trypsinized with 0.025% trypsin in PBSJEDTA as
described" above and plated on chamber slides (Labtek, Nalge Nunc
Intemational). At 48h after transfection, the cells were fixed with 4%
paraformaldehyde (Fisher Scientific) in PBS, pH7.2, and processed for
immunocytochemistry using an anti·rabbit antibody detection system (Santa Cruz
Biotechnology ABC staining system) as described below. The chamber slides
were sequentially washed in PBS, incubated for 10 min in 0.2% Triton X~100
(Fisher Scientific) in PBS, incubated for 20 min in 1.5% normal goat serum in
PBS, transferred to a 1:50 dilution of anti-ER1 antibody (Patemo et 81., 1997) in
normal blocking serum, incubated at RT for two hours, washed in 0.2% Triton X-
100 in PBS twice for 10 min each. The slides were incubated for 30 minutes at
RT in normal blocking serum containing a 1:200 dilution of biotinylated goat-anti
rabbit IgG secondary antibody, washed once with 0.1% Triton X-10D in PBS for 3
min and once with PBS for 3 min. The avidin-biotin-HRP complex from the
detection kit was added to the slides for 30 min, followed by washing in PBS for 3
min. Detection was performed by DAB staining (Sigma-Aldrich) for 4-7 min or
until a brown colour developed. The gasket was then removed from the slides
and the slides were mounted in a 10% glycerol in PBS solution and viewed under
light compound microscope.
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4.2.4 Protein anatysis
For Western blotting, transiently transfected cells were lysed in the CAT
lysis buffer (Boeringher Manheim) on ice for 30 minutes. The protein extracts
were centrifuged at 4°C to pellet the insoluble proteins. The soluble proteins in
the supernatant were precipitated with 100% acetone on ice for 25 minutes
followed by centrifugation at 10,000g for 20 minutes. Protein pellets were
washed with 70% acetone, dried under vacuum and prepared for 50S·
polyacrylamide gel electrophoresis as described Chapter 2. Protein levels were
standardized with the Bio-Rad assay kit as per the manufacturer's directions and
sUbjected to electrophoresis and equal amounts of total protein (200Il9) was
loaded in each well in the gels. Western blots were stained with a 1:1000 dilution
of anti·ER1 antiserum (Paterno at a/., 1997) or a 1:500 dilution of anti.pGAL4
antibody (UBI) as described in Chapter 2 and Western blots were analyzed using
the Chemican detection system (Chemicon Intemationallnc.).
4.3 RESULTS
Subcellular localization of the. ER1 protein was verified using a polyclonal
anti~ER1 antibody to stain transfected NIH 3T3 cells. To test whether ER1
contains transactivation activity, ER1 protein was fused to the ONA·binding
domain of yeast GAL-4 (GAL-4 BO) and the effect of the fusion on CAT reporter
activity was examined. Furthermore, to identify domains in ER1 that may
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mediate its transcriptional effect, deletion mutations of full length ERl eDNA were
constructed and fused to GAL-4 DNA binding domain.
4.3.1 ER1 localizes to the nucleus in transiently transfected cells
Anti-ER1 antibody, directed against a synthetic C-tenninal peptide,
recognizes full-length ER1 protein synthesized in vitro (Paterno at al.. 1997) and
specifically stains the nudei of cells expressing ER1 (Fig. 4.1 B). Cells transfected
with the pcDNA3 vector alone (Fig. 4.1 A) as well as pcDNA3-erl transfected cells
stained with pre-immune serum (data not shown) gave similar patterns and no
specific nudear staining.
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Figure 4.1 Nuclear localization of ER1 in transiently transfected NIH 3T3
cells.
NIH 3T3 cells were transfected with either the pcDNA3 vector alone
(A) or er1-pcDNA3 (B). After 48 h, cells were fixed and stained with
anti-ER1 as described in the "Materials and Methods" section. ER1
is localized within the nucleus in transfected NIH 3T3 cells (B).
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4.3.2 ER1 has transactlvatlon activity.
The fact that ER1 is targeted to the nucleus and that its N-terminus contains
stretches of acidic residues characteristic of acidic activation domains (Paterno et
8/.• 1997), suggests that ER1 may function as a transcription factor. This hypothesis
was investigated by testing the transactivation potential of various regions of the
ER 1 protein. Constructs, containing different regions of arl fused to the GAL4 DNA
binding domain, were used along with a CAT reporter plasmid in transient
transfections. Assays of CAT enzyme levels revealed that, although full-length ER1
did not activate transcription, the N-tenninal region (ER 175), containing all four
acidic amino acid regions stimulated transcription 1D-fold (Fig. 4.2) The
complementary C-terminal portion, ER 176-493, on the other hand, had no
transactivational activity. Interestingly, deletion of the fourth acidic stretch to
produce a construct containing only the first three acidic stretches (ER 1-9B),
resulted in a much more potent transactivator that stimulated transcription BO-fold
(Fig. 4.3). These results suggest the presence of a negative regulatory region in
amino acids 99--175. Further truncation of the N-terminus to generate ER 1·57 and
ER 1-25 completely abolished transactivation. These results demonstrate that the
N-terminus of the ER1 protein contains regions with transcription transactivating
activity and that ER1 has the potential to function as a transcription factor.
In addition to the previously published results, (Paterno et 81., 1997)
described in section 4.3.2, transient transfections and CAT assays were performed
with a deletion construct lacking the fourth acidic stretch (ERA99-175). This
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construct did not give any detectable CAT activity, although it lacked the putative
negative regulatory region (amino acids 99-175). This additional result suggests that
there may be additional negatively acting domainls in the C-terminal portion of ER1.
This idea is also supported by the fact that full-length ER1 does not activate
transcription.
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Figure 4.2 The N terminus of ER1 functions as a transcriptional activator.
NIH 3T3 cells were transiently transfected with various GAL4-ER1
fusion constructs along with a CAT reporter plasmid. After 48 h, CAT
enzyme levels were measured as described in the -Materials and
Methods~ section. Vector denotes the control pM plasmid, containing
only the GAL4 DNA binding domain, whereas the numbers indicate
the amino acids of ER1 encoded by each construct. The value for
each construct represents the fold activation relative to the pM
plasmid, averaged from 3 to 12 independent transfections.
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In order to verify that the differences in fold transactivation of the different
constructs were not due to unequal translation of the different constructs, equal
amounts of total protein from NIH 3T3 cells transfected with the different
constructs were resolved on an 8DS-PAGE gel, transferred to nitrocellulose
membrane and stained with anti-pGAL4 antibody. The Westem blot shows that
the different constructs yield varying amounts of fusion protein (Figure 4.3).
The highest level of protein detected was for the full-length protein (ER 1-493),
which does not have any transactivation activity in the CAT assay. Less protein
was detected for ER 1-175, which activates transcription 10-fold, than for the full-
length protein. Surprisingly, no protein was detected for ER 1·98 (lane 6), which
has the highest transactivation activity in the CAT assay (Figure 4.2). In contrast,
protein was detected for both ER 176-493 (lane 3) and ER.199·175 (lane 7),
neither of which activates transcription. No protein was detected for ER 1-25
(lane 4), ER 1-57 (lane 5), or for the control GAL4 vector (lane 8). Although
these results do show unequal expression of the different fusion constructs, it
was not possible to determine whether the difference was due to unequal
translation of the different constructs or to an detection problem since the fusion
construct that gave the highest transactivation activity (ER 1-98) was not
detected on the blot.
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Figure 4.3 Protein expression levels of transiently transfected ER1 constructs
NIH 3T3 cells were transiently transfected with various GAl4-ER1 fusion
constructs. After 48 h, total protein was extracted and prepared for Western
blotting as described in the "Materials and Methods· section. The Western
blot was stained with anti-pGAL4 (lanes 1-8). The protein loaded in each
lane ;s indicated on the top.
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4.4 DISCUSSION
The GAL4 DNA binding fusion protein has been used extensively to define
the transcriptional activation domains of numerous proteins (Tolnay at aI., 2000;
Weintraub at al., 1991; Nielsen at al., 1992; Sadowski at af., 1988; Sadowski &
Ptashne, 1989). Since no mammalian protein binds to the GAl-4 recognition sites
in the reporter plasmid, determination of the potential transactivating activity of the
fused protein being tested is possible.
Several studies have used pGAL4 SO fusion constructs in combination
with the CAT assay to define transaetivation activity. Activity is measured as the
fold-activation of the CAT enzyme compared with that of the empty pGAL4
vector. For example, the activation domain of thyroid receptor ~1 activates
transcription 4Q-fold (Wilkinson & Towles, 1997); Smad4. which mediates the
transcriptional activation of target genes of the TGF·p signalling pathway,
activates transcription of CAT 25-fold (Shioda et al., 1998); the activation domain
of hEZF activates transcription 50-fold (Yet et aL, 1998). Other studies (Yet at
al., 1998) have reported much higher fold-activation, in the 200 to 300-fold range,
but these numbers were obtained after normalization for transfection efficiency
and protein expression. From the CAT assay kit, the HBx trans-activating factor,
which stimulates the transcription of several cellular and viral genes, was tested
as a positive control for detection of transactivation. The CAT assay kit provides
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a four- to nine-fold increase in the steady state le'lel of CAT protein was detected
in the presence of HBx.
Full-length ER1 protein did not up-regulate transcription but the N-terminal
portion of ER1 (ER 1-175) consisting of aU four acidic stretches up-regulated
transcription 10-fold and the first three acidic (ER 1-98) stretches 8o-fold,
showing the presence of an transactivation domain in ER1. These results also
suggest that a negatively acting domain is located between amino acids 99-176.
It is unclear why full-length ER1 was unable to stimulate transcription, but one
possible explanation is that fusion of ER1 to GAL4 may alter the tertiary structure
of the ER1 protein, affecting its activity. A similar observation was made with the
ET$ transcription factor ER81 fused to the GAL-4 BD, which lost its ability to
activate transcription (Janknecht, 1996) Other proteins have also been identified
for which deletion mutants encoding the activation domains have higher activity
than the full-length proteins. For examplel N-terminal deletion mutants of the
NS5A protein have strong transcriptional activity when fused to the GAL-4 BD,
whereas full length N$5A does not (Tanimoto et aI., 1997). Although full-!ength
ATF-2 protein fused to the GAL-4 80 is inactive, a chimeric protein containing
the ATF-2 N-terminus fused to GAL-4 80 can stimulate the expression of a GAL-
4 dependent reporter (Livingstone et aI., 1995). These results are probably due
to the masking of the activation domains in full-length proteins by inhibitory
domains.
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Another possibility is that ER1 may need to interact with other proteinls to
become transcriptionally active or to expose the activation domains. This has
been shown 10 be the case for NK-4, for which NK-4 dependent transactivation is
augmented after physical interaction with the p300 co-activator (Choi et aI.,
1999).
Ful1hennore, transcription factors often have inhibitory regions masking
their activation domains. Activation and inhibitory domains were identified in the
C-tenninal region of PEBP2ClB1. The inhibitory domain was contained within a
40 amino acid region and was located next to the activation domain, keeping the
full transactivation potential of the full length protein below its optimal level,
probably through intramolecular masking of the activation domain (Vagi et aI.,
1999). IRF·1 has both transactivating domains and inhibitory domains In
addition to inhibiting transactivation activity by the adjacent activation domain in
the lRF·1 protein, one of the inhibitory domains, when fused to the strong
activator VP-16, reduced the transcriptional activity of the latter by 60%. The
authors suggest several models through which inhibitory domains could
potentially act: 1. Inhibitory domains can come in physical contact with the
activator domain, thereby blocking its activity, 2. The inhibitory domain could also
be interacting with the target molecules of the activation domains such as TAFs
or other components of the transcription machinery and 3. The inhibitory domain
may modify the enzymatic activity of stimulators involved in the transcription
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activation process. In vivo, inhibitory activity is probably blocked by processes
such as phosphorylation or protein-protein interaction.
ER1·98 activates transcription aD-fold, but ER1-175 only 1D-fold.
Therefore, the region containing the putative inhibitory domain (99-176) was
deleted to test for transcriptional activity in the absence of the inhibitory region.
However, a deletion construct (ER.6.99-175) fused to the GAl4 SO provided no
transactivational activity. These results may indicate the presence of further
negative regulatory regions in the C-terminal portion of ER1 or once again may
be due to conformational changes created by fusion to GAl BD.
It is important to note that the use of truncated proteins to identify
functionally important regions always involves uncertainty about the proper
folding and conformation of the truncated protein. Removal of one part of a
protein may affect the thermodynamic stability of the protein or alter the
conformation of more distant regions (Tolnay et at, 2000).
Furthermore, deletion constructs are often not translated at the same
levels or the protein products are not equally stable. Western blotting was
therefore used to analyze the levels of protein expressed by the different
constructs (Fig. 4.3).
Protein was detected for the N-terminal portion encoding all four acidic
stretches of ER1 (1-176) and which activates transactivation 1Q-fold. The Westem
blot detected protein for the GAl-4 SO fusions with full length ER1 (1-493), the C·
terminal portion (176-493) and ERi199-175, none of which have transaetivation
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activity. The Western blot (Fig. 4.3) failed to detect protein for the assays
involving ER 1-25, ER 1-78 and ER 1-98, although the latter gave the highest
activity in the transactivalion assay.
It is probable thai the CAT reporter assay detects activity by proteins that
are present at too low levels to be detected by Western blotting. Full-length coding
regions of Id proteins (ld1, Id2, Id3 and Id4) all activate transcription of a GAL4-
responsive reporter gene when fused to GAl-4 BD (Bounpheng at a/., 1999).
However, Western blot analysis failed to detect GAl-4-ld3 protein even though it
had strong transactivation activity. In the case of ER1, however, since the Western
blot also failed to detect the control GAl4 protein, detection limitations cannot be
excluded. At the time these experiments were done, the only anti-ER1 antibody
available was unable to detect most of the fusion constructs. Most of the deletion
constructs lacked the C-terminus portion of the ER1 protein and the antibody was
made against a synthetic peptide encoding part of the C-terminal region of ER1
(Patemo et 81., 1997). Recently, a new anti-ER1 antibody that was prepared
against the full protein has become available. It will be interesting to stain the
Western blot with this new antibody and determine whether the staining patterns
are repeated.
In view of the current Western blotting results, it is possible that the two
fusion constructs for which protein was not detected, ER 1-25 and ER 1-57, also
have transactivation activity and that activity was not detected because protein was
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not produced or the proteins were not adequately stable and are therefore unable
to activate transcription of the reporter gene.
It has been found that acidic activation domains can act synergistically, such
as for the transcription activation domain of RelA, wtlich contains several acidic
modules (Blair et aI., 1994). The first acidic module of ReJA fused to the DNA-
binding region is inactive by itself but a GAl4 fusion protein bearing two or more of
the acidic modules is a very efficient activator of the reporter gene, even though all
the fusion constructs express protein at the same levels (Blair et aI., 1994). No
consensus sequences other than clusters of acidic residues giving a net negative
charge have been found to be common for acidic activation domains. However, it
has been shown that bulky hydrophobic amino acids, such as phenylalanine, play
a critical role in increasing the efficiency of transactivation by the activation
domains of transcriptions factors such as VP16, GAL4, GCN4, Jun, Fos, and ReJA
(Cress & Triezenberg, 1991; Regier et al., 1993; Hope et 8/., 1988; Ma & Ptashne,
1987; Sutherland et 81.,1992; Blair et al., 1994). In the case of ER1, the second
acidic domain contains a phenylalanine residue bracketed by acidic amino acids
(EFDDEOTlEEEEMlEGE). Therefore, it is possible that the first three acidic
domains of ER1 or even all four (since the fusion encoding all four domains does
activate transactivation 10-fold) are all required for transactivation activity,
As discussed above, the activity of inhibitory regions can be modulated
through phosphorylation or protein-protein interactions. In the native protein,
folding in the proper configuration would ensure that the activation domains would
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act in a synergistic fashion and activate transcription. To further define the specific
amino acids that are sufficient for the activation domain, further deletions will have
to be constructed and analyzed. This could prove to be difficult, as activation
domains can be partially deleted and have only a gradualloss of activity (Hope at
a/., 1988; Triezenberg at 8/.,1988).
It is important to note that the pGAL4 system can give false positives and
that it is an artificial system. Non-transcriptional proteins can function as
transcriptional activators when fused to a DNA·binding domain as baits in two-
hybrid screens (Bartel at ai"~ 1993; Warbrick, 1997) and about 0.1-1% of random
Escherichia coli peptides or random synthetic peptides (Ma & Ptashne, 1987) can
substitute as activation domains when tethered to DNA. The ability of ERl to
function as a transcription factor is therefore being confirmed through other
projects in the laboratory, listed below.
The experiments described in this chapter have shown that ER1 localizes to
the nucleus and have provided support for ER1 functioning as a transcription
factor. Other ongoing projects in the lab are investigating DNA·binding ability and
protein-prolein interactions in ER1, other key characteristics of transcription
factors. ER1 has been shown to have consensus sequences for protein·protein
interactions (Paterno at af., 1997). Results demonstrating DNA-binding activity
and/or interaction with proteins associated with the transcription machinery will
help confirm transcriptional activity and determine which genes are transactivated
by ER1.
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The activation domain identified in ER1 (ER 1-98) stimulated high levels of
transactivation activity in the CAT assay (8o-fold) and coupled with intrinsic
translocation to the nucleus of the full protein, it is highly probable that ER1
functions as a transcription factor in vivo. The investigation of the function of ER1
during early development in Xenopus embryos, will be described and discussed in
Chapter 5.
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CHAPTERS FUNCTIONAL CHARACTERIZATION OF erl BY
ITS OVEREXPRESSION XENOPUS EMBRYOS
5.1 INTROOUCTION
A common technique used to elucidate the function of genes and gene
products in developmental and other studies is to over- or under-express them in
vivo. The most effective technique developed to dale for manipulating gene
expression in Xenopus is the injection of cRNA synthesized from the eDNA of
cloned genes. In over-expression studies, cRNA is injected shortly following
fertization of embryos and its effect on development is followed to detect
morphological abnormalities. The function of a protein in particular pathways can
be analysed by looking examining for changes in the expression of molecular
markers representative of particular tissues. Alternatively, the mar1<ers maybe
expressed at specific times. By misregulating a gene and studying the effects,
the functions of the gene and its product and the signalling pathways in which the
latter is involved can be defined.
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5.2 MATERIALS AND METHODS
5.2.1 RNA injection
erl and XFO cRNA was prepared using the Ribomax large scale RNA
production system '(Promega Corporation), as described in Section 3.2.2 and
dissolved in DEPC-treated H20. Embryos were injected with DEPC-treated
dH:!O or 10ng, 509, 2ng, 1ng and 0.509 er1 cRNA in the marginal zone region at
two-cell stage adjacent to the cleavage furrow. Each experimental condition
induded 40-60 embryos and experiments were repeated at least five times.
Morphology differences between control and experimental conditions were
scored and recorded by photographs using a RS Photometries digital
camera,attached to a 52 PT Olympus dissecting microscope. Embryos were
staged (Njeuwkoop, 1994) and deviations from normal development were
soored. Student T-tests were used to anlyze the numbers.
5.2.2 Total RNA extraction and reverse transcription
Embryos were injected at the two-cell stage, as described above, with
DEpe-treated H20, 5ng en cRNA or 5ng XFD cRNA respectively. Five whole
embryos were .transferred to 1.5ml Eppendort" tubes containing 1ml of Tri-
Reagent (Life Technologies. Inc.) and homogenized with a micropipette.
Embryos were collected at stage 10.5. 11.5 and 15. At stage 10.5, since there
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were no morphology differences in the embryos in the three experimental groups
and embryos were randomly selected for total RNA extraction. At stages 11.5
and 15, er1 and XFD·injected embryos with gastllJlation defects were used for
RNA extraction. RNA extraction was performed as described in section 3.2.4.1.
The concentration of the RNA was assayed before use by a combination of
absorbance readings at 260nm (ODz&ol and agarose gel electrophoresis. RT of
the RNA samples was performed as described in Chapter 3.
5.2.3 RT·PCR
Table 5.1 lists forward and reverse primers used for molecular marker
analysis. The number of amplification cycles used for each primer set is also
shown in Table 5.1. PCR reactions for each primer pair were optimized so that
amplifications cycle numbers were in the linear range. Reactions were
performed with increasing numbers of cycles and resolved on electrophoresis
gels. The gels were exposed to autoradiography films, which were examined by
computer scanning densitometry. The cycle numbers were plotted against the
densitometry values to determine the linear and plateau phases.
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Table 5.1 List of primer pairs used for peR reactions
Primer Primer Sequence Expected Slle of Number of Reference
Product PeR cvcle.
BMP-4F 5'GCATGTMGGATMGTCGATC3' 500bp 26 Koster st al., 1991
BMP-4R 5'GATCTCAGACTCMCGGCAC3'
H4·F 5'CGGGATMCATICAGGGTATCACT3' 191 bp 22 Niehrs st a/., 1994
H4-R 5'ATCCATGGCGGTMCTGTCTICCT3'
HoxB9·f 5'GAGGCCACAGTGTMTGTIGG3' 269bp 26 Wright 8t 81.,1990
HoxB9~R 5'ATICCGCTCTGCGCMTTCCC3'
GSC·F 5'GAGCAMGTGGAGGAGGCAG3' 207 bp 30 Cho st 81.,1991
GSC·R 5'CCCACATCGTGGCACTGCTG3'
Xbra·f 5'CMGGATCGTIATCACCTCTG3' 187 bp 26 Smith st al., 1991
Xbra·R 5'TGTGTAGTCTGTAGCAGCAG·3'
XpcrF 5'CACTIAGGGATIGGTCTCAGGAGTC3' 500 bp 24 Sato st 8'.. 1991
xDo-R 5'TGAGGGAGGGCTATGGTCTAGG3'
F, FOfWard; R, Reverse
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5.3 RESULTS
5.3.1 Qver-expresslon of ER1 leads to posterior truncations In the embryo.
Injecting H20 provides a control tor the injection procedure and provides
background levels for abnormalities arising from injection wounds. Injecting RNA
controls is important to monitor morphological abnormalities that may be a factor
when injecting non-physiological amounts of RNA These samples require
controls for contaminants, which may be present after the in vitro synthesis of the
RNA. An appropriate RNA control was not available for en when these
experiments were done. A control er1 RNA with a mutated start ATG codon was
subsequently generated; injection of this RNA, at doses of 1Dog or lower,
generated only morphological abnormalities similar to those observed upon
injecting DEPC-treated H20.
Further dose/response experiments are required to account for
abnormalities due to injecting large amounts of RNA. In cases in which the
phenotype is weak, hundreds of surviving embryos need to be examined in order
to obtain an accurate representation of the injected embryo phenotype (Vize et 8/.,
1991).
er1 cRNA was microinjected into fertilized eggs at twQ.ce1i stage in the
marginal zone region and the embryos were compared with control DEpe-treated
H20 injected embryos for their ability to develop into normal tadpoles. In the
injection experiments, 0.5-10ng of RNA was used, and the injection series was
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repeated at least 5 times. A total of 40-60 embryos were injected per condition in
each experiment. These measures ensured that the phenotype observed upon
injecting en was due to the RNA rather than a non-specific effect.
Injection of RNA at high concentrations (10 ng) resulled in death of 90% of
RNA-injected embryos at late gastrula stages. Embryos injected with RNA at
concentrations of 0.5ng and lower did not show any significant abnormalities over
control embryos. Figure 5.1 shows the percentage of abnormal embryos in the
experimental series injected with DEPC-treated H20, 1 and 2ng er1 respectively.
5% of DEPC~treated HzO, 64% of embryos injected with 2ng er1 and, 32% of
embryos injected with 1ng er1 developed abnormally. Student T·tests showed
that these values were different from each other at 1% significance level (Table
5.2).
Embryos developed normally during early cleavage stages. Abnormalities
in morphology were first observed at gastrulation stages 10·12h post·injection;
gastrulation was incomplete, leaving an enlarged open blastopore and protruding
yolk plugs. Embryos were SCOI"ed at stage 36, three days after fertilization.
Abnormalities were seen in 59% of embryos which were primarily posterior
truncations resulting in normal heads but little or no tails (Figure 5.3). The
remaining 5% of the embryos that developed abnormally had no truncations but
displayed abnormalities such as split tails and bodies, enlarged heads, elongated
shapes and poorly defined organs and tissues. In the control DEPC-treated H20
injected, group. 5% of the embryos developed abnormally. Half of these abnormal
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embryos failed to gastrulate nonnally and developed minor posterior
abnormalities, such as kinked teils andlor spines, and mild posterior truncations
The remainder of the abnormal embryos in the control group had enlarged or
poorly defined heads. The fact that the abnormal phenotype of the embryos
injected with different doses of en cRNA gave primarily one type of phenotype,
posterior truncations as opposed to many different abnormalities seen in the
controls, indicates that the phenotype is en-specific.
In the injection experiments described above, the phenotype of the er1
cRNA injected embryos was observed to be similar to the phenotype of embryos
injected with a dominant negative FGFR, XFD cRNA, previously described in the
literature (Amaya et aI., 1991). Furthermore, since the levels of en RNA had
previously been found to increase in response to FGF treatment (Patemo et aI.,
1997), indicating the ER1 is on the FGF signalling pathway. Therefore, it was
highly interesting to investigate this similarity further and determine the role that
ER1 might play in the FGF signalling pathway. To follow this interest, XFD and
en RNA were injected in embryos for comparison purposes at both the
morphological and molecular levels.
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Figure 5.1 OVer-expresslon of erl cRNA results In abnormal embryos
Embryos were injected with OEPC·treated dH20 (control) or eri cRNA (209 or
109) in the marginal zone region at two-cell stage as desaibed in the -Materials
and Methods· section. After 72h at room temperature, embryos 'Here scored for
abnormal phenotype; the percentage is based on total number (n) of embryos
injected. Abnormal embryos in the erl-injected groups failed to complete
gastrulation normally and as a result had heads but little or no tails (posterior
truncations). The total number of embryos injected and standard deviation values
(error bars) of six individual experiments are shown.
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Table 5.2 Statistical analysis methods for resuhs from er1-lnjected embryos.
The Student T-test was performed at the 1% significance level (Critical T-value c -4.604) and the following algorithm
was used:
HO: Mean of Test1 = Mean otTest2
H1: Mean of Tesl1 'I- Mean of Tesl2
Injections Mean values T-value Interpretations
DEPC-treated HzO 0.05 (Test 1) -6.97 Hypothesis is rejected at the1% significance level.
1n9 ert 0.32 (Test 2) Mean of Test 1 Is signifICantly different from mean of Test 2
DEPC-treated HzO 0.05 (Test 1) -24.78 Hypothesis ;s rejected at the1 % significance level.
2ng erl 0.64 (Test 2) Mean of Test 1 Is significantly different from mean of Test 2
1ng erl 0.32 (Test 1) -7.61 Hypothesis Is rejected at the1% signifICance level.
2ng ert 0.64 (Test 2) Mean of Test 1 is significantly different from mean of Test 2
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Embryos were injected with either 2ng ert or 2ng XFD cRNA and the
phenotypes of embryos were then scored. The abnormal embryos in both the
er1- and XFD-injected groups failed to gastrulate properly, which resulted mainly
in posterior truncations. The abnormal phenotypes from injecting either were
highly similar (Figure 5.3). The percentage abnormal embryos in each group
were compared. 59% of the embryos injected with er1 cRNA and 62% of the
embryos injected with XFD had posterior truncations. These values were not
significantly different at the 1% signifICance level (critical T-value = -4.604; Test
T-value = -0.47 at a: = 0.01).
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Figure 5.2 OVerexpresslon of eri and XFD cRNAs result In similar
percentages of embryos with posterior truncations.
Embryos were injected with DEPC-treated dH20 (control), 2ng en cRNA or 2ng
XFD cRNA in the marginal zone region at tw<rce11 stage as described in the
"Materials and Methods" section. Embryos were left to develop for 72h at room
temperature and scored for abnormalities. Both er1- and XFD-injected embryos
failed to gastrulate properly resulting in posterior truncations (normal heads but
little or no tails). Values were determined as the percentage of number of
embryos injected. Error bars represent the mean (+1-) standard deviation (error
bars) of four individual experiments.
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Figure 5.3 Effects of ER1 over-expression on embryonIc development
Embryos were injected with 2ng efT cRNA or 2119 XFD cRNA, fixed in
MEMFA after 72tl and photographed. Examples are shown of embryos,
which develop normally (normal) and of the posterior truncations observed
in ar1·injected embryos (ER1 phenotype) a nd XFD-injected embryos (XFD
phenotype). scale bar represents 0.1 mm.
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5.3.2 Over-expression of ER1 during Xenopus development
changes in the expression levels of early molecular markers.
Molecular markers were chosen to compare the effect of ER1 to the
effects of XFD, which has been previously characterized (Amaya et aI., 1993) on
representative posterior mesodennal, general mesodennal and anterior
mesodermal markers during early development Embryos were injected with 5ng
of RNA to ensure that there was an abnonnal phenotype in the majority of the
embryos injected since injections of 2ng of RNA resulted in abnormal phenotype
in only approximately 60% of injected embryos (Figure 5.2).
The results presented here are preliminary results and the number of
molecular markers examined was small. However, the effect of XFD
overexpression on the chosen molecular markers has been well characterized
and the primary objective of these experiments was to establish whether there
was a similarity at the molecular level between ER1 and XFD, since similar
phenotypes were observed upon overexpression of both ER1 and XFD. These
experiments were used to establish a working model for further experiments
examining the relationship between ER1 and FGF signal transduction.
The expression levels of the general mesodermal marker Xbra, posterior
markers BMP-4, Xpo, and HoxB9, and the early anterior marker goosecoid in erl
and XFD·injected embryos were examined. The effect of XFD on these markers
has been previously described in the literature (Amaya at 8f., 1993; Isaacs at 81.,
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1994; Pownall st 81.,1996; Holawacz and Sokol, 1999)and was therefore useful
tor comparisons to the effects of sri. Figure 5.4 shows the expression patterns of
XbrB. BMP~, HoxB9, )(PO. and Goosecoid in embryos injected with DEpc·
treated H~. sri or XFD cRNAs during subsequent development al stages 10.5.
11.5 and 15. Histone, H4. was used as an internal and gel loading control.
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Figure 5.4 Effects of overexpressing er1 and XFD on molecular markers
Embryos were injected with DEPC·trealed H20, 5n9 er1 (eRNA
or 5n9 XFD cRNA and RT-peR was performed on ANAs extracted
at stages 10.5, 11.5 and 14.
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5.3.3.1 Erl down-regulates the expression of the mesodermal marker
Xbra
The Xenopus brachyury gene (Xbra) is expressed throughout the marginal
zone and serves as a general mesodermal marker (Smith et aI., 1991). Xbra
transcripts first appear in Xenopus embryos at the mid-blastula transition. The
highest level of Xbra expression is at gastrula stages in the presumptive
mesodermal cells around the blastopore lip, The level of expression starts to
decline at the end of gastrulation but Xbra expression persists in the notochord
during neurula stages
Xbra is induced by either activin A or FGF-2 in animal caps in a
cycloheximide-independent manner, suggesting that it is a general early
mesodermal response gene for mesodermal induction (Smith et at, 1991). It has
been found that the expression of Xbra is regulated by eFGF during development
in Xenopus embryos (Isaacs et aI., 1994) and Xbra levels were up-regulated in
eFGF-injected embryos (Pownall at aI., 1996). In situ hybridization techniques
showed that embryos displayed a complete circle of Xbra expression throughout
the marginal zone whereas XFD embryos lacked Xbra expression in a quarter to
half of the marginal zone (Amaya et aI., 1993). The RT-PCR results presented
here (Fig. 5.4) are consistent with results reported for XFO in the literature: Xbra
expression was lower than for control embryos in XFO-injected embryos at stage
10.5 and there was a complete lack of Xbra expression at stage 11.5 and 15 in
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XFD·injected embryos. Relative to histone control, Xbra expression was similar
to control H20-injected embryos in er1·injecled embryos at stage 10.5 and 11.5
but was much lower than in control embryos at stage 15. Therefore, both XFD
and ER1 over-expression were found to result in the down·regulation of Xbra
expression. Previous experiments have shown that Xbra is necessary for the
formation of posterior mesoderm (Conlon et a/., 1996; Cuncliffe and Smith,
1992). The RT·PCR results described here suggest that ER1 is inhibiting Xbra
expression or is causing a premature decrease in Xbra expression level and thus
acts as a negative regulator of the FGF signalling pathway during mesoderm
induction
5.3.3.2 Erl down-regulates the expression of the ventral marker BMp·
4.
Bone morphogenetic proteins (BMPs) are members of the transforming
growth factor ~ (TGF-~) family, which play diverse roles in embryonic
development (reviewed in Dale & Jones, 1999). BMPs have been shown to be
involved in both mesoderm induction and dorsoventral patteming (reviewed in
Dale & Jones, 1999). BMP-4 transcripts are localized in the ventral and lateral
regions of the gastrula stage embryo, and are absent from the dorsal side
(Falnsod et aI., 1994;Schmidt at aI., 1995). Studies in Xenopus have identified a
number of inhibitory proteins encoded by genes such as chemin and noggin,
which bind to BMP-4, establishing a morphogen gradient of BMP-4 activity, which
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specifies different dorsoventral fates in early gastrulae (reviewed in Dale &
Jones, 1999; Thesis Introduction). Hence high BMP-4 expression in the ventral
side of the embryo results in more ventrally derived tissues whereas inhibition on
the dorsal side of the embryo gives dorsal derivatives. Genetic studies in mice
have shown that BMP-4 plays an important role in mesodermal patterning; mice
with a null mutation in the bmp--4 gene typically die prior to gastrulation, but the
small number that survive typically exhibit disorganised mesoderm and strongly
truncated posterior structures (Winnier et aI., 1995). This phenotype is similar to
that obtained with the over-expression of XFD and arl in Xenopus embryos
(Figure 5.3). The RT-PCR expression asays showed that the level of BMP-4 was
similar to control level in both erl and XFD·injecled embryos at stage 10.5 and
11.5, but lower than control for erl- and XFD-injected embryos at stage 15
(Figure 5.4).
Northrop el al. (1995) showed that BMP-4 rescues the expression of Xbra
and Xcad3, which are also regula1ed by FGF, in XFD-injected embryos. The
authors suggest that BMP-4 is involved in the ventral regulation of these genes.
Our results suggest that, by down-regulating the expression of BMP-4, both XFD
and ERl inhibit the formation of ventrally derived tissues, a process which could
result in posterior truncations.
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5.3.3 Er1 down-regulates the expression of HoxB9, a posterior marker.
Hox genes are widely accepted to be regulators of anteroposterior
specification in animal groups ranging from Drosophila to vertebrates (Holland
and Garcia-Fernandez, 1996;Pownall et a!., 1996;Slack, 1993). The expression
of some Hox genes has been shown to be regulated by FGF signalling during
gastrula and neurula stages, after the period of mesoderm induction (Pownall et
aI., 1996). HoxB9 expression starts at neurula stages and the marker is
expressed at stage 14 in the posterior neural plate from the blastopore to
approximately the middle of the antero-posterior axis in the embryo and is later
expressed in the spinal cord until tailbud stages (Godsave et aI., 1994;Pownall et
aI., 1996). Hoxe9 expression was upregulated in eFGF-injected embryos
(Pownall et aI., 1996b). Pownall et s/., (1998) showed that the activation of Hox
genes during early neurula stages absolutely requires FGF signalling and
transcriptional activation by Xcad3, while the maintenance of. Hox gene
expression in the trunk and tail during later development is independent of both
FGF and Xcad. Since both XFD and ert-injected embryos have severe posterior
truncations (Figure 5.3), it was expected that the expression level of a posterior
marker such as HoxS9 would be much lower than that of control in these
embryos. The RT-peR results showed that HoxB9 expression can be first
detected in control embryos at stage 15 and is considerably and comparably
lower in both ert- and XFD-injected embryos (Fig. 5.4). The down-regulation of
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HoxB9 by ER1 suggests that the FGF signalling pathway, criticaJ to posterior
patterning, is blocked in en-injected embryos.
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5.3.3.4 Expression levels of the posterior marker, Xpo, are unaffected
by over.expression of ert as opposed to XFD.
Xpo is a posterior mesodermal marKer. Xpo expression starts at or shortly
after MaT. The RNA accumulates to a relatively low level, which remains
constant until gastrulation then rapidly and transiently increases in posterior
ectoderm and mesoderm (Sato and Sargent, 1991). Amaya et 81., (1993) found
that Xpo was expressed strongly at the mid-gastrula stage in the lateral and
ventral marginal zones. The authors report high expression levels in posterior
structures at stage 13. Furthermore. Xpo gene expression is induced in animal
caps by either activin A or FGF-2 (Sato and Sargent, 1991). Xpo expression was
found to be up-regulated in eFGF-injected embryos (Pownall et aI., 1996). At
stage 11, Xpo expression was partially inhibited in XFD-injected embryos
(Amaya et aI., 1993). It was therefore expected that Xpo levels would be lower
than control in both XFD and en-injected embryos. RT-PCR analysis showed
that the expression level of Xpo is initially lower than control levels in XFD-
injected embryos at stage 10.5, and is only slightly lower than in control embryo
levels at later stages (Figure 5.4). Amaya et 81., (1993) showed that the level of
Xpo expression was down-regulated at stage 11, but there were no reports
whether this effect was sustained past stage 11. Our results show that, similar to
the results of Amaya et sl., (1993), there is a decrease in the level of Xpo
expression in XFD injected embryos but that this effect is transient. In contrast,
there were no detectable differences between Xpo levels in en-injected and
169
oontrol embryos at stage 10.5 and 11.5 and were only slightly lower in er1-
injected than in control embryos at stage 15.
5.3.3.5 Erl overexpression delays the upregulation of the anterior
marker goosecoid at Xenopus late gastrula stages.
Goosecoid is an anteriorly expressed marker, which encodes a homeobox
containing transcription factor. Goosec:oid is expressed early in the dorsal lip of
the blastopore and the RNA levels decrease during neunJlation (eho et a!.,
1991;PownaU et at, 1996).
In XFD injected embryos, goosecoid levels were lower than that of control
embryos at stage 10.5, similar to controls at stage 11.5, and much higher than for
controls at stage 15 (Fig. 5.4). Expression level of goosecoid was lower in erl-
injected embryos than for controls at stage 10.5, higher than for controls at stage
11.5 and returned to the same level as for control embryos at stage 15 (Fig. 5.4).
Interestingly, goosecoid levels are lower for both erl and XFD-injected
embryos at stage 10.5. The highest expression of goosecoid is seen at stage
11.5 for er1-injected embryos and 15 for XFD-injected embryos. Amaya at al.,
(1993) found that goosecoid expression is not affected by XFD at stage 10, but
did not investigate the effects of XFD on goosecoid expression at later stages.
Pownall et 81. (1996) showed that the expression of goosecoid is down-regulated
by eFGF only during stage 12 and 15. No differences were seen between
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control and eFGF·injected embryos at earlier or later stages. My results suggest
that both ER1 and XFO delay the upregulation in the expression of goosecoid.
The up-regulation of goosecoid by ER1 further supports the hypothesis
that ER1 may be acting as a negative regulator of the FGF signalling pathway
during early Xenopus development. However, the lower expression of goosecoid
in embryos injected with eri and XFD at stage 10.5 will need to be investigated
further by RNase protection assays and in situ hybridization in order to determine
whether eri and XFD repress or delay goosecoid expression at early gastrula
stages. There is a delicate balance in the expression of patterning molecules
during early development in Xenopus. As a negative regulator of the FGF
signalling pathway, ER1 may be shifting the balance in favour of anteriorly
expressed genes such as goosecoid.
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5.4 DISCUSSION
The gross morphological abnonnalities observed from overexpressing
ert were very similar to the phenotype observed by Amaya at a/., (1991) upon
injecting a mutant FGFR, XFD, which contains only an extracellular and a
transmembrane domain and inhibits FGF signalling. When XFD is injected in
embryos. they fail to complete gastrulation. There are major neurula stage
deficiencies in lateral and posterior mesodenn, which later result in extreme trunk
deficiencies and little or no tails but XFD embryos develop nannal heads
(Amaya at aI., 1991).
Truncated posterior phenotype was observed in 64% of the embryos
injected with 2n9 of erl, the remaining embryos had normal phenotypes or minor
defects (Figure 5.1). The percentage of abnormal embryos was only 32% when
embryos are injected with 1ng ert cRNA (Figure 5.1) and no significant
abnormalities are observed when lower amounts of cRNA are injected. The ER1
phenotype (Fig 5.3 B), is very similar to the XFD phenotype for which Amaya at
al. (1991) reported severe posterior truncations in up to 60% of embryos injected
with 4ng to 8ng of XFD cRNA whereas 29% of the injected embryos developed
normally. The authors observed that when XFD is injected in embryos, normal
embryos and less extreme phenotypes were present in the experimental group.
The authors attribute this variation in severity of the phenotype to a non-uniform
distribution of the injected RNA in some embryos and/or a low level of translation
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of the injected cRNA. These factors may also account for the difference in
severity of phenotype in in the 2ng er1-injected embryos, in which 36% of the
embryos develop normally.
There are several lines of evidence indicating that FGF is a potent
posterionzing factor (Amaya et aI., 1993; Cox and Hemmati-Brivanlou, 1995;
Holowacz and Sokol, 1999; Isaacs et aI., 1994;Lamb and Harland, 1995; Pownall
et aI., 1996). It has been shown that FGFs are secreted in the posterior of
gastrula and neurula stage embryos (Isaacs at af., 1992; Tanahill at al., 1992;
Isaacs et al., 1995) and play a role in the posterior development of Xenopus
embryos (Altaba and Melton, 1989, Isaacs et al., 1994). Over-expression of
eFGF in embryos during the gastrula stages produces a characteristic phenotype
of reduction of the head and enlargement of the proctodeum (Isaacs et al., 1994).
This observation of a similar phenotype is an indication that ert, like XFD, may
be involved in blocking the FGF signalling pathway, and that ER1 may be a
natural regulator or inhibitor of the FGF signalling pathway dUring early
developmental processes in the Xenopus embryo. Thus, ER1 may function to
tum off the FGF signalling pathway in villO. However, the similarity in phenotype
between ER1 and XFD overexpression has only been established by scoring
gross morphological defects. In order to further characterize the effects of ER1
on specific tissues and similarity to XFD-injected embryos, it will be necessary to
examine embryos histologically and use a larger array of molecular markers.
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The abnormal phenotype obtained upon over-expressing ER1 is very
similar to the XFD phenotype. Therefore, a molecular profile was established for
ER1 by comparing the effect of over-expression on the expression of
representative mesodermal, posterior and anterior markers on 'Nhich the effects
ofXFD had been previously documented (Amaya at aI., 1993).
Molecular biologists utilize many techniques in gene expression studies.
Some of the most common techniques are Northern blot analysis, RNAse
protection assays and in situ hybridizations. RT-peR remains a relatively new
technique and the technology is continually being optimized. It has proven to be
a more sensitive and discriminating procedure than those mentioned above, as it
permits the analysis of very small amounts of RNA. Furthermore. RT-PCR is a
fairly rapid and simple procedure, in which simultaneous analysis of several
transcripts from total RNA and quantitation can be achieved. One major
shortcoming in using RT-PCR is the high degree of variability associated with the
procedure. In addition to greatly amplifying the target, any errors or
contaminations present are also amplified, thus affecting the accuracy and
reliability of the result. However, with proper experimental design, it can be a
useful technique.
Although the RT-PCR procedure followed here did not allow for
quantitative analysis between the different developmental marker primer sets, the
use of histone to standardize the amount of cDNA used in the PCR amplification
with each primer set did allow comparison of samples. The methodology used
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here allowed qualitative comparison of the effects of XFD and ER1 on embryos.
Further analysis of these markers using in situ hybridization and RNAse
protection assays would complement the RT-PCR results and help give a better
indication of how the expression of these molecules are being quantitatively,
spatially and temporally affected by en over-expression.
Pownall at al. (1996) have previously shown that eFGF up-regulates the
expression of posterior genes such as XhoxC6 (Xlhbox1), HoxA7 (Xhox36),
HoxB9 (Xfhbox6), Xcsd3 and Xpo. These authors also showed that eFGF up-
regulates the expression of Xbra, a mesodermal marker and down-regulates the
expression of anterior markers such as goosecoid and otx2. Conversely, XFD
has been shown to down·regulate the expression of posterior molecular markers
such as Xpo, Xcad3, and HoxB9 and the mesodermal marker Xbra (Amaya at
al., 1993; Pownall at af., 1996; Holawacz and Sokol. 1999). Our RT-PCR results
with ER1 over-expression follow a similar pattem to that of XFD for the
mesodermal marker Xbra, the ventral marker BMP-4 and the posterior marker
HoxB9 and the anterior marker goosecoid.
It is possible that XFD and ER1 are blocking the FGF signalling pathway
at different steps and/or to different extents. Furthermore, XFD shuts down all
signalling cascades triggered by FGF whereas a downstream regUlator like ER1
may be aff8cting only specific pathways triggered by FGF. Hence the different
temporal profiles are seen. It is also of interest to examine the effects of ER1
overexpression on these molecular markers at stages later than stage 15 in order
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to determine whether the effect of ER1 on the expression levels is transient or
sustained, since the expression of the molecular markers examined, such as
HoxB9, only starts at neurula stages. RTMPCR was used in this study, whereas
previous studies of factors other than erl had used in situ hybridization and
RNAse protection assays. In the future, it is therefore of interest to confirm the
erl results presented us'ing such techniques.
When XFD is overexpressed in embryos, there is a reduction in
mesoderm formation, abnormalities arising from the inhibition of normal
gastrulation movements and there are defects in the formation of posterior parts
(Isaacs at al., 1994). II is believed that the mesoderm formation and cell
movement defects are due to loss of Xbra expression and that the posterior
defects are due to a lack of posterior Hox activity (Isaacs et af., 1994; Pownall et
al., 1996). Our results show that erl over-expression results in gross
morphological defects that are very similar to XFD. With the limited number of
molecular markers used in this study and the different temporal profiles of these
markers in response to ER1 and XFD, it may be too early to establish a definite
similarity between the effects of ER1 and XFD at the molecular marker level.
However, the molecular profile established for ER1 suggests that ER1 is a
regulatory molecule, which is up-regulated by FGF pathway (Paterno et aI.,
1997), and negatively regulates the FGF pathway when developmental
processes triggered by FGF signalling, such as mesodermal and posterior
patterning, have been established.
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In the future a larger spectrum of molecular markers, especially dorsal
markers, such as ChorrJin, Noggin (inhibitory to the ventral patterning molecules)
as well as more specific mar1<:ers for tissue patterning, Xnot (notochord) and P-
actin and MyoD (muscle), will confirm whether erl is truly a negative regulator of
specific FGF signalling pathways and characterize the pathways involved.
Isaacs at a1., (1994) used XFD to investigate the role of eFGF in
mesoderm during gastrula stages. When 2-cell stage embryos are injected with
eFGF and animal caps are removed at stage 9 and cultured for three days, the
animal caps develop fluid·filled mesoderm indicating the formation of
mesodermal derivatives Similarly, incubation of animal caps with other FGFs
such as FGF·2 leads to differentiation of the animal caps into mesoderm of a
ventro--Iateral nature. Co--injection of eFGF with XFD leads to a marked reduction
in the auto--induction activity of eFGF (Isaacs et af., 1994). Repeating these types
of experiments with erl and eFGF co-injection or incubating animal caps injected
with erl with FGF·2 would demonstrate whether ER1 can suppress the
mesodel1Tl'-inducing activity of FGFs and act in an inhibitory fashion similar to
XFD by shutting off FGF signalling.
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SECTION IV
CHAPTER 6: GENERAL DISCUSSION, FUTURE DIRECTIONS
AND CONCLUSION
6.1 GENERAL DISCUSSION
One of the main objectives of modem developmental biology has been
and continues to be the identification of the molecular nature of inducing signals
in early development. It is now known that key developmental pathways are
triggered by members of the TGF·p and FGF families (see section 1.4-1.8). FGF
has multiple functions in early development, including mesoderm formation,
gastrulation movements and anteroposterior patterning (Slack, 1994). Er1 was
identified as a novel gene, whose expression is upregulated by FGF during
mesoderm induction in Xenopus, (Patemo at al., 1997). The objectives of this
thesis were to characterize the expression pattern of ER1 protein, identify
mechanisms regulating its expression and characterize and understand its
function.
It was shown that the spaticHemporal nuclear translocation of ER1 is
tightly regulated during early development (Chapters 2 and 3). Nudear
localization of ER1 is possibly a response to the FGF signalling pathway as
suggested by the inhibition of nudear localization of ER1 in XFD-injected
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embryos (Chapter 3). Transcriptional activity was established for deletion
constructs of ER1 protein, suggesting that ER1 may function as a transcription
factor in vivo (Chapter 4). The results in Chapter 5 suggest that ER1 may
function as a negative regulator of the FGF signalling pathway, since
overexpression of ER1 gives a phenotype that is the converse of that of FGF
overexpression and is Similar to that of XFD overexpression. FurthermOfe, ER1
overexpression results in downregulation in the expression of molecular markers
such as Xbra and HoxBox9. whose expression are activated, and in the case of
Xbra, maintained, by FGF.
ER1 is initially translocated to the cell nuclei of the marginal zone and
animal hemisphere of the early blastula stages embryo, regions that have been
shown to express the three maternal forms of FGF: FGF-2, FGF-9 and
eFGF(Song and Slack, 1994; reviewed in Isaacs, 1997). At gastrula and neurula
stages, ER1 is ubiquitously present in all nuclei (Chapter 2). Gastrula and
neurula stages are also stages where maternally expressed and zygotically
expressed FGFs overlap in the embryo. Zygotic eFGF is expressed in the
blastopore region at gastrulation (reviewed in Isaacs, 1997). At gastrula and
neurula stages. FGF expression spans both the animal and vegetal regions of
the embryo. At tailbud stages ER1 can be found in the nuclei of the notochord,
somites. arid spinal cord, but starts to disappear from the nuclei of the brain and
epidermis. FGF-2 is zygotically expressed in the CNS and somitic tissue (Song
and Slack, 1994) and eFGF is expressed in the notochord as well as in the
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posterior region of the embryo (reviewed in Isaacs, 1997). At these stages, I
found that ER1 is also nuclear in endodermal and mesodermal tissues and not in
ectodermally derived tissues. The expression pattem of ER1 protein along with
the inhibition of its nuclear localization by XFD suggests that ER1 may be a
downstream effector of the FGF signalling pathway whose nuclear localization is
analogous to the expression of various FGFs dUring early development
The major role of the FGF pathway during early development is the
formation of mesoderm and posterior structures in the Xenopus embryo. The
current model for the role of FGFs during early amphibian development proposes
that the matemal pool of FGFs is required to provide sub-threshold stimulation of
the tyrosine kinase signal transduction pathway in the animal hemisphere
(reviewed in Isaacs, 1997). The FGFs act as competence factors to vegetally
localized inducing signals from activin-like factors (Hemmati-Brinvanlou and
Melton, 1992; Thomsen and Melton, 1993). It has been proposed that
mesoderm forms in the marginal zone because it is a region where FGF factors
and activin-like factors overlap (Cornell and Kimelman, 1994). It has been shown
that FGF is involved downstream of earty mesoderm inductive signals in the
maintenance of the Xbra expression in mesoderm precursors (Smith st 81.,
1997). FGF signals also regulate the expression of the caudal gene family
member Xcad3 (Northrop and Kimelman, 1994; Pownall at al., 1996), which has
8 critical function in the regulation of posterior hox genes (Isaacs at al., 1998).
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The results presented in Chapter 5 suggest that ER1 is functioning as a
negative" regulator of the FGF pathway. However, the expression of FGFs and
the nuclear localiZation pattem of ER1 in the embryo show that ER1 is nuclear in
regions where FGFs are active such as the marginal zone in the earty embryo
and later in the blastopore region, notochord, somites, and CNS As a
transcription factor, ER1 may be either 1) enhancing the transcription of genes
whose products act to shut down the FGF pathway or 2) repressing the
transcription of genes required for the FGF response. One possible scenario is
that the supression of the FGF pathway is happening at varying levels in the
embryo. Inductive events are the result of finely balanced positive and negative
interactions. Therefore, the ability of ER1 to shut down the FGF pathway may be
dependent on several factors such as the level of expression of the FGFs in
different regions of the embryo as well as the expression of other spatially
specific factors, which interact with the FGF pathway.
It is interesting to note that ER1 may be remaining cytoplasmic until the
FGF pathway is itself activated as illustrated by the expression of activated
MAPK, detected for the first time in the embryo at stage 8 (LaBonne and
Whitman, 1997; Christen and Slack, 1999). ER1 also first localizes to the nuclei
of marginal zone cells at stage 8. MAPK is initially present in the region of the
future blastopore at stage 8 and around the blastoporal ring at gastrula stages.
The staining pattem of activated MAPK has been fully described and is indicative
of the regions in which FGF signals are being transduced through FGFR1
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(LaBonne and Whitman 1997; Christen and Slack 1999; Umbhauer et a/., 2000;
section 1.7.3). ER1 may be regulating the FGF pathway at a different threshold
in the regions where MAPK is fully active, such as in mesodermal derivatives,
than in tissues such as the ectoderm, where activated MAPK does not appear to
be expressed (Christen and Slack, 1999). First, ER1 becomes undetectable in
the nuclei of ectodermal derivatives, where FGF may no longer be active, and
remains nuclear in tissues that retain FGF expression such as semites and
notochord.
Although nuclear localization of ER1 coincides with the activation of the
MAPK signalling cascade by FGF at blastula stages, it has not yet been
determined whether the MAPK cascade is reqUired for nuclear translocation of
ER1. Preliminary results, not presented in this thesis, have shown that
overexpression of a dominant-negative MAPK kinase (MEK~DN), which blocks
MAPK signalling, does not prevent nuclear localization of ER1. It is therefore
possible that nuclear localization of ER1 is triggered by a different signalling
pathway, such as the PLCy1 or PI3'K pathway. Previous work in our laboratory
has shown that both phosphorylated PLCy1 and PI3'K associate with FGFR1
during early blastula stages in Xenopus (Gillespie et af., 1992; Ryan & Gillespie,
1994; Ryan at af., 1998). Similar to MAPK signalling, these two pathways are
therefore also adivated correct time for initiating ER1 nuclear localization. The
results in Chapter 3 showed that XFO blocks nuclear localization of ER1
However, XFD blocks FGF signalling at the receptor level and abrogates all FGF
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signalling. Further worK is therefore required to determine which specific
downstream FGF signalling cascade may lead to dephosphorylation of ER1
associated proteins and consequent nudear localization of ER1.
The results presented in this thesis suggest a model whereby FGF
signalling is modulated by a negative feedback mechanism through ER1. As
illustrated in Figure 6.1, nuclear localization of ER1 is initiated by FGF signalling.
Signalling initiated by FGF leads to the dephosphorylation of proteins associated
with ER1, and the latter event is correlated with translocation of ER1 to the
nudeus. Once in the nudeus, ER1 may be activating the transcription of genes
whose products act to inhibit FGF signalling, and/or repress the transcription of
genes required for the FGF·mediated response during mesoderm induction.
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Figure 6.1 A model illustrating the putative mechanism underlying
nuclear localization and function of ER1.
The above model proposes a negative feedback loop on FGF
signalling by ER1. FGF binding to FGFRs triggers the FGF
signalling cascade, which may lead to dephosphorylation
events on ER1 associated proteins, followed by nuclear
localization of ER1. In the nuclelS, ER1 possibly activates
transcription of genels whose products shut down FGF
signalling and/or represses the transcription of genels required
for mesoderm induction
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6.2 FUTURE OIRECnONS
Future experiments of relevance to each of the chapters were discussed
earlier. After considering all the infonnation presented, there are several areas of
immediate interest, which can be examined to confirm the results presented in
this thesis.
6.2.1 Down~regulating ER1 expression or function.
Overexpression of ER1 in the embryo was useful in determining its
function in the embryo. Another strategy often used in unravelling the function of
proteins is the use of dominant-negative mutants. The dominant-negative FGF
receptor, XFO, has been crucial in investigating some functions of FGFs in the
embryo. Qverexpression of a dominant-negative ER1 will provide further clues
to the function of the protein. Hence, jf ER1 truly functions as a regulator of the
FGF pathway, overexpression of a dominant-negative fonn of the protein should
give reverse effects to those observed here from overexpressing ER1 and
putatively similar results to overexpression of FGFs. A protein, which does not
exhibit transcriptional activity but blocks endogenous ER1 activity by interacting
with nonnal ER1 partners, should act as a good dominant-negative. Other
ongoing projects in the laboratory are attempting to characterize the ER1
domains ER1, that may be responsible for DNA·binding or protein·protein
interaction.
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Other strategies, which can be used to cause -loss of function", are RNA
interference and the use of antisense oligonucleotides and morpholino
oligonucleotides. RNA interference technology, using double stranded RNA
corresponding to the gene of interest, has been found to be effective in
downregulating gene expression in Xenopus (Nakano at al., 2000). Antisense
oligonucleotides lead to degradation of mRNA and morpholino oligonucleotides
act by preventing the translation of specific mRNAs into protein, hence ablating
the function of the gene of interest (Summerton & Weller, 1997).
6.2.2 Determining which FGF pathway is responsible for nuclear translocation of
ERl
FGF signalling activates three major pathways, RasIMAPK, PLCy1 and
PI3'K pathways (reviewed in Powers at al., 2000). The work in this thesis has
shown that nuclear localization of ER1 is tightly regulated during early
developmental stages and is under the control of FGF signalling. Dominant-
negative mutants (such as dominant negative MAPK) and chemical inhibitors
(such as wortmannin, which inhibits PI3'K, and U713122, the synthetic inhibitor
of PlCy) or neutralizing antibodies to specific components of these pathways,
will help determine which of the three pathways listed above is responsible for
nuclear localization of ER1. Nuclear localization of ER1 in response to
overexpressing of dominant-negative mutants or chemical inhibitors can be
verified by whole-mount antibody staining.
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Activated PlCy and PI3'K both associate with FGFR during mesoderm
induction (Ryan & Gillespie, 1994; Ryan at 81., 1998). Activated PKC, a
component of the PlCy pathway, has been detected in FGF-treated explants
(Gillespie et 81., 1992). Simultaneous treatment of explants with TPA (an
activator of PKC) and FGF results in significant inhibition of mesoderm induction
by FGF, suggesting that activation of PKC oould be part of a negative feedback
mechanism on the FGF mesoderm induction pathway (Gillespie et a/., 1992). It
is possible that nuclear localization of ER1 is triggered by either the PLCy or the
PI3'K pathway as part of a negative feedback mechanism to regulate mesoderm
induction by FGF.
6.2.3 Further characterization of the role of ER1 during mesoderm induction
A low level of activity from maternal FGFs is required for the transcription
of the mesodermal marker Xbra in late blastula marginal zone. Xbra then
activates the zygotic expression of eFGF in the earty mesoderm leading to a
period of autocatalytic activity of eFGF and Xbra in the nascent mesoderm of the
marginal zone. During gastrula and neurula stages, eFGF continues to regulate
the expression of Xbra in the blastopore region and the notochord. The FGF-
Xbra autocatalytic pathway is important for the establishment of the mesoderm.
Different types of mesoderm are induced in animal cap explants at varying doses
of FGFs (Slack €It a1., 1987; Slack at a1., 1988). Mesodermal tissue of a ventral
nature such as mesenchyme and mesothelium are induced at low doses, and of
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a more lateral nature such as muscle at higher doses (reviewed in Isaacs, 1997).
These induced caps express mesodermal molecular markers such as Xbra.
Animals caps from embryos injected with ert should inhibit the ability of FGFs to
induce mesoderm. This would be verified by visually scoring the explants,
looking at the expression of molecular markers for mesoderm and by histological
analysis for mesodermal derivatives. These experiments will confirm the ability
of ER1 to regulate the mesoderm-inducing ability of FGF.
6.2.4 Investigating effect of ER1 on the MAPK pathway and rescue of the ER1
phenotype by activated MAPK.
Mesoderm and posterior signals transduce through FGFR1 by activation
of the RasIMAPK pathway (Umbhauer et a/., 2000). Transduction of FGF signals
leading to Xbrs maintenance involves Ras, Raf and the MAPK cascade (Gotoh et
al., 1995; LaBonne at a/., 1995; MacNicol et al., 1993; Umbhauer et al., 1995)
and downstream the heterodimeric AP-1 transcription factor (Kim et a/., 1998). In
Xenopus, the FGF family seems to be responsible for the full pattern of activated
MAPK in early development since activation can be blocked completely by XFD
until tailbud stages (Christen and Slack, 1999). The connection of ER1 to the
FGF signalling pathway can be further investigated by looking at the effect of
ER1 on the expression of activated MAPK. The level of activated MAPK in
embryos overexpressiog ER1 can be verified by whole mount staining or by
Western blotting
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SillC8 ER1 may be having a negative regulatory effect on FGF signalling
during mesoderm induction and the main pathway activated dUring mesoderm
induction by FGF is through MAPK, it will be interesting to determine whether
expression of activated MAPK will rescue the phenotype seen in embryos
overexpressing ER1.
6.3 CONCLUSION
This study has provided insight into the expression and function of ER1 in
the Xenopus embryo. There is preliminary evidence that ER1 functions as a
transcription factor. The protein has a tightly regulated spatio--temporal nuclear
localization pattem in the embryo. Investigation of the mechanisms regulating
this nuclear localization pattem suggests that nuclear translocation of ER1 is
regulated by changes in ER1-associated phosphoserine proteins, triggered by
the FGF signalling pathway in Xenopus embryos.
ER1 over-expression results in posterior truncations in the embryo and
inhibits the expression of mesodermal and posterior markers, which are induced
by FGF, suggesting that ER1 is a modulator of the FGF pathway. Further
expression analysis of a larger array of markers will support this premise. In
addition, analysis of the response of components specific to the FGF signalling
pathway will determine the specificity of the ER1-FGF connection.
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